company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 13:43:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,48418000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 13:43:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,48418000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 13:43:14+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,11239000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 13:43:14+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,11239000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 13:43:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,37179000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 13:43:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15626000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 13:43:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8372000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 13:43:14+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3128000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 13:43:14+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-1759000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 13:43:14+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2534000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 13:43:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27901000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 13:43:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9278000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 13:43:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9278000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 13:43:14+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1023000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 13:43:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8255000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 13:43:14+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-69000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 13:43:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8186000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 13:43:14+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,42000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 13:43:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8144000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 13:43:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6917000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 13:43:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.18
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 13:43:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6939000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 13:43:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.17
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 13:43:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6901700000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 13:43:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.18
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 10:00:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,48296000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 10:00:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,48296000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 10:00:55+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8112000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 10:00:55+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8112000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 10:00:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,40184000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 10:00:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14537000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 10:00:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8578000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 10:00:55+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,2668000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 10:00:55+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2032000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 10:00:55+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2675000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 10:00:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,30490000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 10:00:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9694000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 10:00:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9694000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 10:00:55+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1645000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 10:00:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8049000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 10:00:55+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,78000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 10:00:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8127000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 10:00:55+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,23000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 10:00:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8104000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 10:00:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6727000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 10:00:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.2
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 10:00:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6750000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 10:00:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.2
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 10:00:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6753300000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 10:00:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.2
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q3,2008-06-30,2008-09-28,2009-11-05 17:15:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11973000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q3,2008-06-30,2008-09-28,2009-11-05 17:15:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11973000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q3,2008-06-30,2008-09-28,2009-11-05 17:15:33+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2122000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q3,2008-06-30,2008-09-28,2009-11-05 17:15:33+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2122000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q3,2008-06-30,2008-09-28,2009-11-05 17:15:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9851000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q3,2008-06-30,2008-09-28,2009-11-05 17:15:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3523000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q3,2008-06-30,2008-09-28,2009-11-05 17:15:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1898000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q3,2008-06-30,2008-09-28,2009-11-05 17:15:33+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,621000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q3,2008-06-30,2008-09-28,2009-11-05 17:15:33+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,721000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q3,2008-06-30,2008-09-28,2009-11-05 17:15:33+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,366000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q3,2008-06-30,2008-09-28,2009-11-05 17:15:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7129000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q3,2008-06-30,2008-09-28,2009-11-05 17:15:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2722000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q3,2008-06-30,2008-09-28,2009-11-05 17:15:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2722000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q3,2008-06-30,2008-09-28,2009-11-05 17:15:33+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,463000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q3,2008-06-30,2008-09-28,2009-11-05 17:15:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2259000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q3,2008-06-30,2008-09-28,2009-11-05 17:15:33+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,25000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q3,2008-06-30,2008-09-28,2009-11-05 17:15:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2284000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q3,2008-06-30,2008-09-28,2009-11-05 17:15:33+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,6000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q3,2008-06-30,2008-09-28,2009-11-05 17:15:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2278000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q3,2008-06-30,2008-09-28,2009-11-05 17:15:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6718000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q3,2008-06-30,2008-09-28,2009-11-05 17:15:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.34
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q3,2008-06-30,2008-09-28,2009-11-05 17:15:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6736000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q3,2008-06-30,2008-09-28,2009-11-05 17:15:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.34
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q3,2008-06-30,2008-09-28,2009-11-05 17:15:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6700000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q3,2008-06-30,2008-09-28,2009-11-05 17:15:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.34
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q3,2008-06-30,2008-09-28,2009-11-05 17:15:33+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.32
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q2,2008-03-31,2008-06-29,2009-08-06 17:20:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12129000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q2,2008-03-31,2008-06-29,2009-08-06 17:20:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12129000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q2,2008-03-31,2008-06-29,2009-08-06 17:20:32+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2289000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q2,2008-03-31,2008-06-29,2009-08-06 17:20:32+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2289000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q2,2008-03-31,2008-06-29,2009-08-06 17:20:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9840000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q2,2008-03-31,2008-06-29,2009-08-06 17:20:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3863000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q2,2008-03-31,2008-06-29,2009-08-06 17:20:32+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2122000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q2,2008-03-31,2008-06-29,2009-08-06 17:20:32+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,663000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q2,2008-03-31,2008-06-29,2009-08-06 17:20:32+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-167000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q2,2008-03-31,2008-06-29,2009-08-06 17:20:32+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,569000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q2,2008-03-31,2008-06-29,2009-08-06 17:20:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7050000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q2,2008-03-31,2008-06-29,2009-08-06 17:20:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2790000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q2,2008-03-31,2008-06-29,2009-08-06 17:20:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2790000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q2,2008-03-31,2008-06-29,2009-08-06 17:20:32+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,25000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q2,2008-03-31,2008-06-29,2009-08-06 17:20:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2765000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q2,2008-03-31,2008-06-29,2009-08-06 17:20:32+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,17000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q2,2008-03-31,2008-06-29,2009-08-06 17:20:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2782000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q2,2008-03-31,2008-06-29,2009-08-06 17:20:32+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,6000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q2,2008-03-31,2008-06-29,2009-08-06 17:20:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2776000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q2,2008-03-31,2008-06-29,2009-08-06 17:20:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6732000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q2,2008-03-31,2008-06-29,2009-08-06 17:20:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.41
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q2,2008-03-31,2008-06-29,2009-08-06 17:20:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6748000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q2,2008-03-31,2008-06-29,2009-08-06 17:20:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.41
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q2,2008-03-31,2008-06-29,2009-08-06 17:20:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6770700000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q2,2008-03-31,2008-06-29,2009-08-06 17:20:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.41
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2008.0,Q2,2008-03-31,2008-06-29,2009-08-06 17:20:32+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.32
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q4,2009-09-28,2009-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15797000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q4,2009-09-28,2009-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15797000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q4,2009-09-28,2009-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3506000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q4,2009-09-28,2009-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3506000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q4,2009-09-28,2009-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12291000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q4,2009-09-28,2009-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5244000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q4,2009-09-28,2009-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2840000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q4,2009-09-28,2009-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1122000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q4,2009-09-28,2009-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,110000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q4,2009-09-28,2009-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,3124000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q4,2009-09-28,2009-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12440000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q4,2009-09-28,2009-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-149000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q4,2009-09-28,2009-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-149000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q4,2009-09-28,2009-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-807000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q4,2009-09-28,2009-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,658000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q4,2009-09-28,2009-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,108000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q4,2009-09-28,2009-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,766000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q4,2009-09-28,2009-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-1000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q4,2009-09-28,2009-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,767000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q4,2009-09-28,2009-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,7007000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q4,2009-09-28,2009-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.05
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q4,2009-09-28,2009-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,7045000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q4,2009-09-28,2009-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.06
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q4,2009-09-28,2009-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,7020300000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q4,2009-09-28,2009-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.05
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q4,2009-09-28,2009-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.64
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 17:07:08+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,49269000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 17:07:08+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,49269000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 17:07:08+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8459000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 17:07:08+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8459000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 17:07:08+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,40810000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 17:07:08+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14752000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 17:07:08+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7892000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 17:07:08+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,2877000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 17:07:08+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,285000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 17:07:08+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,4330000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 17:07:08+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,30136000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 17:07:08+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10674000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 17:07:08+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,10674000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 17:07:08+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2145000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 17:07:08+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8529000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 17:07:08+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,114000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 17:07:08+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8643000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 17:07:08+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,8000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 17:07:08+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8635000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 17:07:08+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,7007000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 17:07:08+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.23
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 17:07:08+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,7045000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 17:07:08+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.23
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 17:07:08+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,7020300000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 17:07:08+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.23
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3YTD,2009-01-01,2009-09-27,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,33472000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3YTD,2009-01-01,2009-09-27,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,33472000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3YTD,2009-01-01,2009-09-27,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4953000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3YTD,2009-01-01,2009-09-27,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4953000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3YTD,2009-01-01,2009-09-27,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,28519000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3YTD,2009-01-01,2009-09-27,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9508000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3YTD,2009-01-01,2009-09-27,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5052000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3YTD,2009-01-01,2009-09-27,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1755000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3YTD,2009-01-01,2009-09-27,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,175000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3YTD,2009-01-01,2009-09-27,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1206000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3YTD,2009-01-01,2009-09-27,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17696000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3YTD,2009-01-01,2009-09-27,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10823000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3YTD,2009-01-01,2009-09-27,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,10823000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3YTD,2009-01-01,2009-09-27,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2952000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3YTD,2009-01-01,2009-09-27,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7871000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3YTD,2009-01-01,2009-09-27,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,6000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3YTD,2009-01-01,2009-09-27,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7877000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3YTD,2009-01-01,2009-09-27,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,9000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3YTD,2009-01-01,2009-09-27,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7868000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3YTD,2009-01-01,2009-09-27,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6730000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3YTD,2009-01-01,2009-09-27,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.18
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3YTD,2009-01-01,2009-09-27,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6762000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3YTD,2009-01-01,2009-09-27,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.17
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3YTD,2009-01-01,2009-09-27,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6693000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3YTD,2009-01-01,2009-09-27,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.18
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3YTD,2009-01-01,2009-09-27,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.64
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3,2009-06-29,2009-09-27,2010-11-12 10:11:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11621000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3,2009-06-29,2009-09-27,2010-11-12 10:11:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11621000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3,2009-06-29,2009-09-27,2010-11-12 10:11:48+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1789000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3,2009-06-29,2009-09-27,2010-11-12 10:11:48+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1789000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3,2009-06-29,2009-09-27,2010-11-12 10:11:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9832000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3,2009-06-29,2009-09-27,2010-11-12 10:11:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3282000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3,2009-06-29,2009-09-27,2010-11-12 10:11:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1632000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3,2009-06-29,2009-09-27,2010-11-12 10:11:48+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,594000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3,2009-06-29,2009-09-27,2010-11-12 10:11:48+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,160000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3,2009-06-29,2009-09-27,2010-11-12 10:11:48+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,193000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3,2009-06-29,2009-09-27,2010-11-12 10:11:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5861000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3,2009-06-29,2009-09-27,2010-11-12 10:11:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3971000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3,2009-06-29,2009-09-27,2010-11-12 10:11:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3971000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3,2009-06-29,2009-09-27,2010-11-12 10:11:48+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1092000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3,2009-06-29,2009-09-27,2010-11-12 10:11:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2879000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3,2009-06-29,2009-09-27,2010-11-12 10:11:48+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,2000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3,2009-06-29,2009-09-27,2010-11-12 10:11:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2881000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3,2009-06-29,2009-09-27,2010-11-12 10:11:48+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,3000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3,2009-06-29,2009-09-27,2010-11-12 10:11:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2878000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3,2009-06-29,2009-09-27,2010-11-12 10:11:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6730000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3,2009-06-29,2009-09-27,2010-11-12 10:11:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.43
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3,2009-06-29,2009-09-27,2010-11-12 10:11:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6762000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3,2009-06-29,2009-09-27,2010-11-12 10:11:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.43
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3,2009-06-29,2009-09-27,2010-11-12 10:11:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6693000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3,2009-06-29,2009-09-27,2010-11-12 10:11:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.43
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q3,2009-06-29,2009-09-27,2010-11-12 10:11:48+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.16
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2YTD,2009-01-01,2009-06-28,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,21851000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2YTD,2009-01-01,2009-06-28,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,21851000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2YTD,2009-01-01,2009-06-28,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3164000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2YTD,2009-01-01,2009-06-28,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3164000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2YTD,2009-01-01,2009-06-28,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18687000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2YTD,2009-01-01,2009-06-28,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6226000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2YTD,2009-01-01,2009-06-28,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3420000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2YTD,2009-01-01,2009-06-28,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1161000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2YTD,2009-01-01,2009-06-28,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,15000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2YTD,2009-01-01,2009-06-28,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1013000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2YTD,2009-01-01,2009-06-28,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11835000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2YTD,2009-01-01,2009-06-28,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6852000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2YTD,2009-01-01,2009-06-28,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6852000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2YTD,2009-01-01,2009-06-28,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1860000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2YTD,2009-01-01,2009-06-28,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4992000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2YTD,2009-01-01,2009-06-28,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,4000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2YTD,2009-01-01,2009-06-28,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4996000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2YTD,2009-01-01,2009-06-28,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,6000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2YTD,2009-01-01,2009-06-28,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4990000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2YTD,2009-01-01,2009-06-28,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6728000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2YTD,2009-01-01,2009-06-28,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.75
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2YTD,2009-01-01,2009-06-28,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6752000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2YTD,2009-01-01,2009-06-28,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.74
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2YTD,2009-01-01,2009-06-28,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6650000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2YTD,2009-01-01,2009-06-28,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.75
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2YTD,2009-01-01,2009-06-28,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.48
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2,2009-03-30,2009-06-28,2010-08-12 16:54:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10984000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2,2009-03-30,2009-06-28,2010-08-12 16:54:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10984000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2,2009-03-30,2009-06-28,2010-08-12 16:54:27+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1756000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2,2009-03-30,2009-06-28,2010-08-12 16:54:27+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1756000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2,2009-03-30,2009-06-28,2010-08-12 16:54:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9228000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2,2009-03-30,2009-06-28,2010-08-12 16:54:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3350000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2,2009-03-30,2009-06-28,2010-08-12 16:54:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1715000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2,2009-03-30,2009-06-28,2010-08-12 16:54:27+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,583000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2,2009-03-30,2009-06-28,2010-08-12 16:54:27+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,72000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2,2009-03-30,2009-06-28,2010-08-12 16:54:27+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,459000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2,2009-03-30,2009-06-28,2010-08-12 16:54:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6179000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2,2009-03-30,2009-06-28,2010-08-12 16:54:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3049000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2,2009-03-30,2009-06-28,2010-08-12 16:54:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3049000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2,2009-03-30,2009-06-28,2010-08-12 16:54:27+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,786000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2,2009-03-30,2009-06-28,2010-08-12 16:54:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2263000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2,2009-03-30,2009-06-28,2010-08-12 16:54:27+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,3000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2,2009-03-30,2009-06-28,2010-08-12 16:54:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2266000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2,2009-03-30,2009-06-28,2010-08-12 16:54:27+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,5000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2,2009-03-30,2009-06-28,2010-08-12 16:54:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2261000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2,2009-03-30,2009-06-28,2010-08-12 16:54:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6728000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2,2009-03-30,2009-06-28,2010-08-12 16:54:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.34
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2,2009-03-30,2009-06-28,2010-08-12 16:54:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6752000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2,2009-03-30,2009-06-28,2010-08-12 16:54:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.34
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2,2009-03-30,2009-06-28,2010-08-12 16:54:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6650000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2,2009-03-30,2009-06-28,2010-08-12 16:54:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.34
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q2,2009-03-30,2009-06-28,2010-08-12 16:54:27+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.16
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q1,2009-01-01,2009-03-29,2010-05-13 16:44:46+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10867000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q1,2009-01-01,2009-03-29,2010-05-13 16:44:46+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10867000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q1,2009-01-01,2009-03-29,2010-05-13 16:44:46+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1408000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q1,2009-01-01,2009-03-29,2010-05-13 16:44:46+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1408000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q1,2009-01-01,2009-03-29,2010-05-13 16:44:46+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9459000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q1,2009-01-01,2009-03-29,2010-05-13 16:44:46+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2876000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q1,2009-01-01,2009-03-29,2010-05-13 16:44:46+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1705000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q1,2009-01-01,2009-03-29,2010-05-13 16:44:46+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,578000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q1,2009-01-01,2009-03-29,2010-05-13 16:44:46+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-57000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q1,2009-01-01,2009-03-29,2010-05-13 16:44:46+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,554000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q1,2009-01-01,2009-03-29,2010-05-13 16:44:46+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5656000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q1,2009-01-01,2009-03-29,2010-05-13 16:44:46+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3803000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q1,2009-01-01,2009-03-29,2010-05-13 16:44:46+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3803000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q1,2009-01-01,2009-03-29,2010-05-13 16:44:46+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1074000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q1,2009-01-01,2009-03-29,2010-05-13 16:44:46+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2729000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q1,2009-01-01,2009-03-29,2010-05-13 16:44:46+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,1000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q1,2009-01-01,2009-03-29,2010-05-13 16:44:46+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2730000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q1,2009-01-01,2009-03-29,2010-05-13 16:44:46+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q1,2009-01-01,2009-03-29,2010-05-13 16:44:46+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2729000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q1,2009-01-01,2009-03-29,2010-05-13 16:44:46+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6723000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q1,2009-01-01,2009-03-29,2010-05-13 16:44:46+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.41
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q1,2009-01-01,2009-03-29,2010-05-13 16:44:46+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6753000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q1,2009-01-01,2009-03-29,2010-05-13 16:44:46+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.4
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q1,2009-01-01,2009-03-29,2010-05-13 16:44:46+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6656100000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q1,2009-01-01,2009-03-29,2010-05-13 16:44:46+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.41
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2009.0,Q1,2009-01-01,2009-03-29,2010-05-13 16:44:46+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.32
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q4,2010-10-04,2010-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15462000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q4,2010-10-04,2010-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15462000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q4,2010-10-04,2010-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3112000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q4,2010-10-04,2010-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3112000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q4,2010-10-04,2010-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12350000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q4,2010-10-04,2010-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5197000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q4,2010-10-04,2010-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2819000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q4,2010-10-04,2010-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1392000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q4,2010-10-04,2010-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,905000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q4,2010-10-04,2010-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1055000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q4,2010-10-04,2010-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11368000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q4,2010-10-04,2010-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,982000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q4,2010-10-04,2010-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,982000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q4,2010-10-04,2010-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-2012000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q4,2010-10-04,2010-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2994000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q4,2010-10-04,2010-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-97000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q4,2010-10-04,2010-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2897000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q4,2010-10-04,2010-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,7000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q4,2010-10-04,2010-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2890000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q4,2010-10-04,2010-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,8036000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q4,2010-10-04,2010-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.36
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q4,2010-10-04,2010-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,8074000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q4,2010-10-04,2010-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.35
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q4,2010-10-04,2010-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,8016500000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q4,2010-10-04,2010-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.36
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q4,2010-10-04,2010-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.18
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:57:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,65165000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:57:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,65165000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:57:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,14788000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:57:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,14788000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:57:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,50377000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:57:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,18973000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:57:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9483000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:57:54+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,5364000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:57:54+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,3941000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:57:54+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,3145000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:57:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,40906000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:57:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9471000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:57:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9471000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:57:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1153000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:57:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8318000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:57:54+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-30000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:57:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8288000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:57:54+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,31000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:57:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8257000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:57:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,8036000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:57:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.03
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:57:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,8074000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:57:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.02
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:57:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,8016500000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:57:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.03
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:57:54+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.72
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3YTD,2010-01-01,2010-10-03,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,49703000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3YTD,2010-01-01,2010-10-03,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,49703000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3YTD,2010-01-01,2010-10-03,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,11676000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3YTD,2010-01-01,2010-10-03,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,11676000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3YTD,2010-01-01,2010-10-03,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,38027000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3YTD,2010-01-01,2010-10-03,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,13776000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3YTD,2010-01-01,2010-10-03,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6664000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3YTD,2010-01-01,2010-10-03,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3972000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3YTD,2010-01-01,2010-10-03,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,3036000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3YTD,2010-01-01,2010-10-03,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2090000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3YTD,2010-01-01,2010-10-03,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,29538000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3YTD,2010-01-01,2010-10-03,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,8489000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3YTD,2010-01-01,2010-10-03,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8489000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3YTD,2010-01-01,2010-10-03,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3165000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3YTD,2010-01-01,2010-10-03,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5324000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3YTD,2010-01-01,2010-10-03,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,67000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3YTD,2010-01-01,2010-10-03,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5391000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3YTD,2010-01-01,2010-10-03,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,24000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3YTD,2010-01-01,2010-10-03,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5367000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3YTD,2010-01-01,2010-10-03,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,8027000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3YTD,2010-01-01,2010-10-03,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.67
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3YTD,2010-01-01,2010-10-03,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,8057000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3YTD,2010-01-01,2010-10-03,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.67
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3YTD,2010-01-01,2010-10-03,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,7872700000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3YTD,2010-01-01,2010-10-03,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.67
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3YTD,2010-01-01,2010-10-03,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.54
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3TTM,2009-09-28,2010-10-03,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,65500000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3TTM,2009-09-28,2010-10-03,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,65500000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3TTM,2009-09-28,2010-10-03,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,15182000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3TTM,2009-09-28,2010-10-03,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,15182000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3TTM,2009-09-28,2010-10-03,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,50318000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3TTM,2009-09-28,2010-10-03,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,19020000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3TTM,2009-09-28,2010-10-03,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9504000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3TTM,2009-09-28,2010-10-03,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,5094000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3TTM,2009-09-28,2010-10-03,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,3146000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3TTM,2009-09-28,2010-10-03,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,5214000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3TTM,2009-09-28,2010-10-03,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,41978000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3TTM,2009-09-28,2010-10-03,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,8340000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3TTM,2009-09-28,2010-10-03,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8340000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3TTM,2009-09-28,2010-10-03,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2358000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3TTM,2009-09-28,2010-10-03,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5982000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3TTM,2009-09-28,2010-10-03,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,175000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3TTM,2009-09-28,2010-10-03,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6157000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3TTM,2009-09-28,2010-10-03,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,23000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3TTM,2009-09-28,2010-10-03,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6134000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3TTM,2009-09-28,2010-10-03,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,8027000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3TTM,2009-09-28,2010-10-03,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.72
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3TTM,2009-09-28,2010-10-03,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,8057000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3TTM,2009-09-28,2010-10-03,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.73
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3TTM,2009-09-28,2010-10-03,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,7872700000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3TTM,2009-09-28,2010-10-03,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.72
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3TTM,2009-09-28,2010-10-03,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.1
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3,2010-07-05,2010-10-03,2011-11-10 16:50:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15995000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3,2010-07-05,2010-10-03,2011-11-10 16:50:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15995000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3,2010-07-05,2010-10-03,2011-11-10 16:50:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3790000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3,2010-07-05,2010-10-03,2011-11-10 16:50:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3790000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3,2010-07-05,2010-10-03,2011-11-10 16:50:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12205000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3,2010-07-05,2010-10-03,2011-11-10 16:50:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4599000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3,2010-07-05,2010-10-03,2011-11-10 16:50:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2188000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3,2010-07-05,2010-10-03,2011-11-10 16:50:30+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1156000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3,2010-07-05,2010-10-03,2011-11-10 16:50:30+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2349000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3,2010-07-05,2010-10-03,2011-11-10 16:50:30+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,499000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3,2010-07-05,2010-10-03,2011-11-10 16:50:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10791000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3,2010-07-05,2010-10-03,2011-11-10 16:50:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1414000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3,2010-07-05,2010-10-03,2011-11-10 16:50:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1414000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3,2010-07-05,2010-10-03,2011-11-10 16:50:30+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,558000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3,2010-07-05,2010-10-03,2011-11-10 16:50:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,856000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3,2010-07-05,2010-10-03,2011-11-10 16:50:30+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,15000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3,2010-07-05,2010-10-03,2011-11-10 16:50:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,871000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3,2010-07-05,2010-10-03,2011-11-10 16:50:30+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,5000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3,2010-07-05,2010-10-03,2011-11-10 16:50:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,866000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3,2010-07-05,2010-10-03,2011-11-10 16:50:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,8027000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3,2010-07-05,2010-10-03,2011-11-10 16:50:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.11
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3,2010-07-05,2010-10-03,2011-11-10 16:50:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,8057000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3,2010-07-05,2010-10-03,2011-11-10 16:50:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.11
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3,2010-07-05,2010-10-03,2011-11-10 16:50:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,7872700000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3,2010-07-05,2010-10-03,2011-11-10 16:50:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.11
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q3,2010-07-05,2010-10-03,2011-11-10 16:50:30+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.18
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2YTD,2010-01-01,2010-07-04,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,33708000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2YTD,2010-01-01,2010-07-04,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,33708000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2YTD,2010-01-01,2010-07-04,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7886000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2YTD,2010-01-01,2010-07-04,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7886000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2YTD,2010-01-01,2010-07-04,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,25822000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2YTD,2010-01-01,2010-07-04,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9177000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2YTD,2010-01-01,2010-07-04,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4476000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2YTD,2010-01-01,2010-07-04,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,2816000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2YTD,2010-01-01,2010-07-04,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,687000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2YTD,2010-01-01,2010-07-04,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1591000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2YTD,2010-01-01,2010-07-04,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18747000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2YTD,2010-01-01,2010-07-04,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7075000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2YTD,2010-01-01,2010-07-04,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,7075000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2YTD,2010-01-01,2010-07-04,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2607000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2YTD,2010-01-01,2010-07-04,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4468000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2YTD,2010-01-01,2010-07-04,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,52000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2YTD,2010-01-01,2010-07-04,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4520000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2YTD,2010-01-01,2010-07-04,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,19000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2YTD,2010-01-01,2010-07-04,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4501000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2YTD,2010-01-01,2010-07-04,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,8046000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2YTD,2010-01-01,2010-07-04,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.56
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2YTD,2010-01-01,2010-07-04,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,8072000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2YTD,2010-01-01,2010-07-04,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.56
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2YTD,2010-01-01,2010-07-04,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,7983900000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2YTD,2010-01-01,2010-07-04,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.56
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2YTD,2010-01-01,2010-07-04,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.36
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2TTM,2009-06-29,2010-07-04,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,61126000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2TTM,2009-06-29,2010-07-04,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,61126000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2TTM,2009-06-29,2010-07-04,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,13181000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2TTM,2009-06-29,2010-07-04,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,13181000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2TTM,2009-06-29,2010-07-04,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,47945000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2TTM,2009-06-29,2010-07-04,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,17703000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2TTM,2009-06-29,2010-07-04,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8948000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2TTM,2009-06-29,2010-07-04,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4532000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2TTM,2009-06-29,2010-07-04,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,957000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2TTM,2009-06-29,2010-07-04,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,4908000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2TTM,2009-06-29,2010-07-04,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,37048000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2TTM,2009-06-29,2010-07-04,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10897000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2TTM,2009-06-29,2010-07-04,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,10897000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2TTM,2009-06-29,2010-07-04,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2892000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2TTM,2009-06-29,2010-07-04,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8005000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2TTM,2009-06-29,2010-07-04,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,162000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2TTM,2009-06-29,2010-07-04,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8167000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2TTM,2009-06-29,2010-07-04,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,21000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2TTM,2009-06-29,2010-07-04,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8146000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2TTM,2009-06-29,2010-07-04,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,8046000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2TTM,2009-06-29,2010-07-04,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.04
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2TTM,2009-06-29,2010-07-04,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,8072000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2TTM,2009-06-29,2010-07-04,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.05
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2TTM,2009-06-29,2010-07-04,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,7983900000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2TTM,2009-06-29,2010-07-04,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.04
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2TTM,2009-06-29,2010-07-04,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.12
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2,2010-04-05,2010-07-04,2011-08-11 15:51:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,17132000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2,2010-04-05,2010-07-04,2011-08-11 15:51:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,17132000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2,2010-04-05,2010-07-04,2011-08-11 15:51:15+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3684000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2,2010-04-05,2010-07-04,2011-08-11 15:51:15+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3684000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2,2010-04-05,2010-07-04,2011-08-11 15:51:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13448000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2,2010-04-05,2010-07-04,2011-08-11 15:51:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4774000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2,2010-04-05,2010-07-04,2011-08-11 15:51:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2181000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2,2010-04-05,2010-07-04,2011-08-11 15:51:15+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1407000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2,2010-04-05,2010-07-04,2011-08-11 15:51:15+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,275000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2,2010-04-05,2010-07-04,2011-08-11 15:51:15+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,885000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2,2010-04-05,2010-07-04,2011-08-11 15:51:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9522000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2,2010-04-05,2010-07-04,2011-08-11 15:51:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3926000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2,2010-04-05,2010-07-04,2011-08-11 15:51:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3926000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2,2010-04-05,2010-07-04,2011-08-11 15:51:15+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1472000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2,2010-04-05,2010-07-04,2011-08-11 15:51:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2454000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2,2010-04-05,2010-07-04,2011-08-11 15:51:15+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,31000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2,2010-04-05,2010-07-04,2011-08-11 15:51:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2485000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2,2010-04-05,2010-07-04,2011-08-11 15:51:15+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,10000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2,2010-04-05,2010-07-04,2011-08-11 15:51:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2475000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2,2010-04-05,2010-07-04,2011-08-11 15:51:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,8046000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2,2010-04-05,2010-07-04,2011-08-11 15:51:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.31
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2,2010-04-05,2010-07-04,2011-08-11 15:51:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,8072000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2,2010-04-05,2010-07-04,2011-08-11 15:51:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.31
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2,2010-04-05,2010-07-04,2011-08-11 15:51:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,7983900000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2,2010-04-05,2010-07-04,2011-08-11 15:51:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.31
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q2,2010-04-05,2010-07-04,2011-08-11 15:51:15+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.18
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1TTM,2009-03-30,2010-04-04,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,54978000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1TTM,2009-03-30,2010-04-04,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,54978000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1TTM,2009-03-30,2010-04-04,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,11253000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1TTM,2009-03-30,2010-04-04,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,11253000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1TTM,2009-03-30,2010-04-04,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,43725000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1TTM,2009-03-30,2010-04-04,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,16279000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1TTM,2009-03-30,2010-04-04,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8482000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1TTM,2009-03-30,2010-04-04,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3708000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1TTM,2009-03-30,2010-04-04,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,754000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1TTM,2009-03-30,2010-04-04,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,4482000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1TTM,2009-03-30,2010-04-04,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,33705000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1TTM,2009-03-30,2010-04-04,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10020000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1TTM,2009-03-30,2010-04-04,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,10020000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1TTM,2009-03-30,2010-04-04,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2206000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1TTM,2009-03-30,2010-04-04,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7814000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1TTM,2009-03-30,2010-04-04,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,134000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1TTM,2009-03-30,2010-04-04,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7948000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1TTM,2009-03-30,2010-04-04,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,16000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1TTM,2009-03-30,2010-04-04,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7932000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1TTM,2009-03-30,2010-04-04,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,8061000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1TTM,2009-03-30,2010-04-04,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.07
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1TTM,2009-03-30,2010-04-04,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,8101000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1TTM,2009-03-30,2010-04-04,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.08
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1TTM,2009-03-30,2010-04-04,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,8104000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1TTM,2009-03-30,2010-04-04,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.07
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1TTM,2009-03-30,2010-04-04,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.14
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1,2010-01-01,2010-04-04,2011-05-12 15:48:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16576000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1,2010-01-01,2010-04-04,2011-05-12 15:48:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16576000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1,2010-01-01,2010-04-04,2011-05-12 15:48:27+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4202000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1,2010-01-01,2010-04-04,2011-05-12 15:48:27+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4202000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1,2010-01-01,2010-04-04,2011-05-12 15:48:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12374000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1,2010-01-01,2010-04-04,2011-05-12 15:48:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4403000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1,2010-01-01,2010-04-04,2011-05-12 15:48:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2295000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1,2010-01-01,2010-04-04,2011-05-12 15:48:27+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1409000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1,2010-01-01,2010-04-04,2011-05-12 15:48:27+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,412000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1,2010-01-01,2010-04-04,2011-05-12 15:48:27+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,706000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1,2010-01-01,2010-04-04,2011-05-12 15:48:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9225000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1,2010-01-01,2010-04-04,2011-05-12 15:48:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3149000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1,2010-01-01,2010-04-04,2011-05-12 15:48:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3149000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1,2010-01-01,2010-04-04,2011-05-12 15:48:27+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1135000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1,2010-01-01,2010-04-04,2011-05-12 15:48:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2014000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1,2010-01-01,2010-04-04,2011-05-12 15:48:27+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,21000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1,2010-01-01,2010-04-04,2011-05-12 15:48:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2035000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1,2010-01-01,2010-04-04,2011-05-12 15:48:27+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,9000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1,2010-01-01,2010-04-04,2011-05-12 15:48:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2026000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1,2010-01-01,2010-04-04,2011-05-12 15:48:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,8061000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1,2010-01-01,2010-04-04,2011-05-12 15:48:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.25
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1,2010-01-01,2010-04-04,2011-05-12 15:48:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,8101000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1,2010-01-01,2010-04-04,2011-05-12 15:48:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.25
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1,2010-01-01,2010-04-04,2011-05-12 15:48:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,8104000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1,2010-01-01,2010-04-04,2011-05-12 15:48:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.25
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2010.0,Q1,2010-01-01,2010-04-04,2011-05-12 15:48:27+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.18
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q4,2011-10-03,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11439000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q4,2011-10-03,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11439000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q4,2011-10-03,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1827000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q4,2011-10-03,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1827000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q4,2011-10-03,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9612000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q4,2011-10-03,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3821000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q4,2011-10-03,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2183000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q4,2011-10-03,2011-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1316000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q4,2011-10-03,2011-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,689000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q4,2011-10-03,2011-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,379000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q4,2011-10-03,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8388000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q4,2011-10-03,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1224000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q4,2011-10-03,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1224000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q4,2011-10-03,2011-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,434000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q4,2011-10-03,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,790000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q4,2011-10-03,2011-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,658000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q4,2011-10-03,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1448000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q4,2011-10-03,2011-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,9000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q4,2011-10-03,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1439000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q4,2011-10-03,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,7817000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q4,2011-10-03,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.19
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q4,2011-10-03,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,7870000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q4,2011-10-03,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.18
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q4,2011-10-03,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,7819500000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q4,2011-10-03,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.19
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q4,2011-10-03,2011-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.2
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:38:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,61035000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:38:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,61035000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:38:15+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,12500000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:38:15+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,12500000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:38:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,48535000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:38:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,17581000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:38:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8681000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:38:15+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,5465000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:38:15+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2486000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:38:15+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2841000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:38:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,37054000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:38:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,11481000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:38:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,11481000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:38:15+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3621000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:38:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7860000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:38:15+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,2189000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:38:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,10049000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:38:15+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,40000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:38:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,10009000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:38:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,7817000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:38:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.28
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:38:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,7870000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:38:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.27
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:38:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,7819500000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:38:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.28
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:38:15+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.8
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3YTD,2011-01-01,2011-10-02,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,49596000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3YTD,2011-01-01,2011-10-02,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,49596000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3YTD,2011-01-01,2011-10-02,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,10673000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3YTD,2011-01-01,2011-10-02,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,10673000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3YTD,2011-01-01,2011-10-02,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,38923000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3YTD,2011-01-01,2011-10-02,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,13760000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3YTD,2011-01-01,2011-10-02,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6498000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3YTD,2011-01-01,2011-10-02,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4149000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3YTD,2011-01-01,2011-10-02,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1797000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3YTD,2011-01-01,2011-10-02,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2462000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3YTD,2011-01-01,2011-10-02,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,28666000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3YTD,2011-01-01,2011-10-02,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10257000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3YTD,2011-01-01,2011-10-02,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,10257000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3YTD,2011-01-01,2011-10-02,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3187000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3YTD,2011-01-01,2011-10-02,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7070000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3YTD,2011-01-01,2011-10-02,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,1531000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3YTD,2011-01-01,2011-10-02,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8601000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3YTD,2011-01-01,2011-10-02,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,31000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3YTD,2011-01-01,2011-10-02,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8570000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3YTD,2011-01-01,2011-10-02,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,7770000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3YTD,2011-01-01,2011-10-02,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.09
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3YTD,2011-01-01,2011-10-02,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,7810000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3YTD,2011-01-01,2011-10-02,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.09
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3YTD,2011-01-01,2011-10-02,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,7787500000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3YTD,2011-01-01,2011-10-02,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.09
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3YTD,2011-01-01,2011-10-02,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.6
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3TTM,2010-10-04,2011-10-02,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,65058000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3TTM,2010-10-04,2011-10-02,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,65058000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3TTM,2010-10-04,2011-10-02,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,13785000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3TTM,2010-10-04,2011-10-02,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,13785000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3TTM,2010-10-04,2011-10-02,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,51273000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3TTM,2010-10-04,2011-10-02,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,18957000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3TTM,2010-10-04,2011-10-02,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9317000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3TTM,2010-10-04,2011-10-02,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,5541000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3TTM,2010-10-04,2011-10-02,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2702000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3TTM,2010-10-04,2011-10-02,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,3517000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3TTM,2010-10-04,2011-10-02,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,40034000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3TTM,2010-10-04,2011-10-02,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,11239000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3TTM,2010-10-04,2011-10-02,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,11239000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3TTM,2010-10-04,2011-10-02,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1175000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3TTM,2010-10-04,2011-10-02,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10064000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3TTM,2010-10-04,2011-10-02,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,1434000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3TTM,2010-10-04,2011-10-02,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,11498000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3TTM,2010-10-04,2011-10-02,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,38000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3TTM,2010-10-04,2011-10-02,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,11460000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3TTM,2010-10-04,2011-10-02,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,7770000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3TTM,2010-10-04,2011-10-02,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.45
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3TTM,2010-10-04,2011-10-02,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,7810000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3TTM,2010-10-04,2011-10-02,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.44
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3TTM,2010-10-04,2011-10-02,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,7787500000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3TTM,2010-10-04,2011-10-02,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.45
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3TTM,2010-10-04,2011-10-02,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.78
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3,2011-07-04,2011-10-02,2012-11-09 13:39:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16609000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3,2011-07-04,2011-10-02,2012-11-09 13:39:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16609000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3,2011-07-04,2011-10-02,2012-11-09 13:39:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3409000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3,2011-07-04,2011-10-02,2012-11-09 13:39:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3409000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3,2011-07-04,2011-10-02,2012-11-09 13:39:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13200000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3,2011-07-04,2011-10-02,2012-11-09 13:39:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4457000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3,2011-07-04,2011-10-02,2012-11-09 13:39:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2176000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3,2011-07-04,2011-10-02,2012-11-09 13:39:54+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1389000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3,2011-07-04,2011-10-02,2012-11-09 13:39:54+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,547000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3,2011-07-04,2011-10-02,2012-11-09 13:39:54+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1090000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3,2011-07-04,2011-10-02,2012-11-09 13:39:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9659000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3,2011-07-04,2011-10-02,2012-11-09 13:39:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3541000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3,2011-07-04,2011-10-02,2012-11-09 13:39:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3541000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3,2011-07-04,2011-10-02,2012-11-09 13:39:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1216000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3,2011-07-04,2011-10-02,2012-11-09 13:39:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2325000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3,2011-07-04,2011-10-02,2012-11-09 13:39:54+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,1424000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3,2011-07-04,2011-10-02,2012-11-09 13:39:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3749000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3,2011-07-04,2011-10-02,2012-11-09 13:39:54+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,11000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3,2011-07-04,2011-10-02,2012-11-09 13:39:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3738000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3,2011-07-04,2011-10-02,2012-11-09 13:39:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,7770000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3,2011-07-04,2011-10-02,2012-11-09 13:39:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.48
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3,2011-07-04,2011-10-02,2012-11-09 13:39:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,7810000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3,2011-07-04,2011-10-02,2012-11-09 13:39:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.48
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3,2011-07-04,2011-10-02,2012-11-09 13:39:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,7787500000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3,2011-07-04,2011-10-02,2012-11-09 13:39:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.48
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q3,2011-07-04,2011-10-02,2012-11-09 13:39:54+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.2
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2,2011-04-04,2011-07-03,2012-08-09 17:26:18+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16485000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2,2011-04-04,2011-07-03,2012-08-09 17:26:18+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16485000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2,2011-04-04,2011-07-03,2012-08-09 17:26:18+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3571000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2,2011-04-04,2011-07-03,2012-08-09 17:26:18+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3571000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2,2011-04-04,2011-07-03,2012-08-09 17:26:18+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12914000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2,2011-04-04,2011-07-03,2012-08-09 17:26:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4800000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2,2011-04-04,2011-07-03,2012-08-09 17:26:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2231000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2,2011-04-04,2011-07-03,2012-08-09 17:26:18+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1384000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2,2011-04-04,2011-07-03,2012-08-09 17:26:18+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,423000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2,2011-04-04,2011-07-03,2012-08-09 17:26:18+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,478000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2,2011-04-04,2011-07-03,2012-08-09 17:26:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9316000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2,2011-04-04,2011-07-03,2012-08-09 17:26:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3598000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2,2011-04-04,2011-07-03,2012-08-09 17:26:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3598000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2,2011-04-04,2011-07-03,2012-08-09 17:26:18+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1077000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2,2011-04-04,2011-07-03,2012-08-09 17:26:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2521000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2,2011-04-04,2011-07-03,2012-08-09 17:26:18+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,97000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2,2011-04-04,2011-07-03,2012-08-09 17:26:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2618000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2,2011-04-04,2011-07-03,2012-08-09 17:26:18+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,8000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2,2011-04-04,2011-07-03,2012-08-09 17:26:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2610000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2,2011-04-04,2011-07-03,2012-08-09 17:26:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,7875000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2,2011-04-04,2011-07-03,2012-08-09 17:26:18+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.33
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2,2011-04-04,2011-07-03,2012-08-09 17:26:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,7935000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2,2011-04-04,2011-07-03,2012-08-09 17:26:18+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.33
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2,2011-04-04,2011-07-03,2012-08-09 17:26:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,7909100000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2,2011-04-04,2011-07-03,2012-08-09 17:26:18+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.33
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2,2011-04-04,2011-07-03,2012-08-09 17:26:18+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.2
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2YTD,2011-01-01,2011-07-03,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,32987000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2YTD,2011-01-01,2011-07-03,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,32987000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2YTD,2011-01-01,2011-07-03,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7264000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2YTD,2011-01-01,2011-07-03,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7264000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2YTD,2011-01-01,2011-07-03,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,25723000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2YTD,2011-01-01,2011-07-03,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9303000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2YTD,2011-01-01,2011-07-03,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4322000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2YTD,2011-01-01,2011-07-03,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,2760000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2YTD,2011-01-01,2011-07-03,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1250000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2YTD,2011-01-01,2011-07-03,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1372000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2YTD,2011-01-01,2011-07-03,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19007000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2YTD,2011-01-01,2011-07-03,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6716000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2YTD,2011-01-01,2011-07-03,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6716000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2YTD,2011-01-01,2011-07-03,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1971000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2YTD,2011-01-01,2011-07-03,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4745000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2YTD,2011-01-01,2011-07-03,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,107000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2YTD,2011-01-01,2011-07-03,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4852000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2YTD,2011-01-01,2011-07-03,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,20000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2YTD,2011-01-01,2011-07-03,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4832000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2YTD,2011-01-01,2011-07-03,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,7875000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2YTD,2011-01-01,2011-07-03,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.61
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2YTD,2011-01-01,2011-07-03,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,7935000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2YTD,2011-01-01,2011-07-03,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.61
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2YTD,2011-01-01,2011-07-03,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,7909100000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2YTD,2011-01-01,2011-07-03,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.61
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2YTD,2011-01-01,2011-07-03,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.4
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2TTM,2010-07-05,2011-07-03,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,64444000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2TTM,2010-07-05,2011-07-03,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,64444000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2TTM,2010-07-05,2011-07-03,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,14166000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2TTM,2010-07-05,2011-07-03,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,14166000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2TTM,2010-07-05,2011-07-03,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,50278000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2TTM,2010-07-05,2011-07-03,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,19099000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2TTM,2010-07-05,2011-07-03,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9329000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2TTM,2010-07-05,2011-07-03,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,5308000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2TTM,2010-07-05,2011-07-03,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,4504000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2TTM,2010-07-05,2011-07-03,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2926000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2TTM,2010-07-05,2011-07-03,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,41166000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2TTM,2010-07-05,2011-07-03,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9112000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2TTM,2010-07-05,2011-07-03,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9112000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2TTM,2010-07-05,2011-07-03,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,517000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2TTM,2010-07-05,2011-07-03,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8595000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2TTM,2010-07-05,2011-07-03,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,25000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2TTM,2010-07-05,2011-07-03,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8620000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2TTM,2010-07-05,2011-07-03,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,32000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2TTM,2010-07-05,2011-07-03,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8588000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2TTM,2010-07-05,2011-07-03,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,7875000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2TTM,2010-07-05,2011-07-03,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.08
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2TTM,2010-07-05,2011-07-03,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,7935000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2TTM,2010-07-05,2011-07-03,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.07
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2TTM,2010-07-05,2011-07-03,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,7909100000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2TTM,2010-07-05,2011-07-03,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.08
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q2TTM,2010-07-05,2011-07-03,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.76
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1TTM,2010-04-05,2011-04-03,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,65091000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1TTM,2010-04-05,2011-04-03,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,65091000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1TTM,2010-04-05,2011-04-03,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,14279000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1TTM,2010-04-05,2011-04-03,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,14279000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1TTM,2010-04-05,2011-04-03,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,50812000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1TTM,2010-04-05,2011-04-03,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,19073000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1TTM,2010-04-05,2011-04-03,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9279000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1TTM,2010-04-05,2011-04-03,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,5331000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1TTM,2010-04-05,2011-04-03,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,4356000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1TTM,2010-04-05,2011-04-03,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,3333000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1TTM,2010-04-05,2011-04-03,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,41372000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1TTM,2010-04-05,2011-04-03,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9440000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1TTM,2010-04-05,2011-04-03,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9440000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1TTM,2010-04-05,2011-04-03,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,912000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1TTM,2010-04-05,2011-04-03,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8528000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1TTM,2010-04-05,2011-04-03,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-41000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1TTM,2010-04-05,2011-04-03,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8487000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1TTM,2010-04-05,2011-04-03,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,34000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1TTM,2010-04-05,2011-04-03,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8453000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1TTM,2010-04-05,2011-04-03,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,7982000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1TTM,2010-04-05,2011-04-03,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.06
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1TTM,2010-04-05,2011-04-03,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,8035000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1TTM,2010-04-05,2011-04-03,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.05
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1TTM,2010-04-05,2011-04-03,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,7935700000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1TTM,2010-04-05,2011-04-03,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.06
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1TTM,2010-04-05,2011-04-03,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.74
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1,2011-01-01,2011-04-03,2012-05-10 17:19:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16502000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1,2011-01-01,2011-04-03,2012-05-10 17:19:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16502000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1,2011-01-01,2011-04-03,2012-05-10 17:19:13+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3693000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1,2011-01-01,2011-04-03,2012-05-10 17:19:13+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3693000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1,2011-01-01,2011-04-03,2012-05-10 17:19:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12809000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1,2011-01-01,2011-04-03,2012-05-10 17:19:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4503000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1,2011-01-01,2011-04-03,2012-05-10 17:19:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2091000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1,2011-01-01,2011-04-03,2012-05-10 17:19:13+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1376000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1,2011-01-01,2011-04-03,2012-05-10 17:19:13+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,827000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1,2011-01-01,2011-04-03,2012-05-10 17:19:13+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,894000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1,2011-01-01,2011-04-03,2012-05-10 17:19:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9691000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1,2011-01-01,2011-04-03,2012-05-10 17:19:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3118000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1,2011-01-01,2011-04-03,2012-05-10 17:19:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3118000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1,2011-01-01,2011-04-03,2012-05-10 17:19:13+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,894000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1,2011-01-01,2011-04-03,2012-05-10 17:19:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2224000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1,2011-01-01,2011-04-03,2012-05-10 17:19:13+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,10000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1,2011-01-01,2011-04-03,2012-05-10 17:19:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2234000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1,2011-01-01,2011-04-03,2012-05-10 17:19:13+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,12000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1,2011-01-01,2011-04-03,2012-05-10 17:19:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2222000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1,2011-01-01,2011-04-03,2012-05-10 17:19:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,7982000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1,2011-01-01,2011-04-03,2012-05-10 17:19:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.28
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1,2011-01-01,2011-04-03,2012-05-10 17:19:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,8035000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1,2011-01-01,2011-04-03,2012-05-10 17:19:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.28
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1,2011-01-01,2011-04-03,2012-05-10 17:19:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,7935700000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1,2011-01-01,2011-04-03,2012-05-10 17:19:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.28
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2011.0,Q1,2011-01-01,2011-04-03,2012-05-10 17:19:13+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.2
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12851000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12851000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2391000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2391000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10460000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4047000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1933000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1203000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-3283000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,717000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4617000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5843000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4022000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4022000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1821000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,513000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1308000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,5013000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6321000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,6000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6315000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,7442000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.85
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,7508000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.84
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,7433700000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.85
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q4,2012-10-01,2012-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.22
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 16:38:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,54657000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 16:38:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,54657000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 16:38:16+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9821000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 16:38:16+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9821000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 16:38:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,44836000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 16:38:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15171000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 16:38:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7482000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 16:38:16+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,5109000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 16:38:16+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1810000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 16:38:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,29572000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 16:38:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,15264000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 16:38:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4022000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 16:38:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4022000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 16:38:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,11242000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 16:38:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2221000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 16:38:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9021000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 16:38:16+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,5577000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 16:38:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,14598000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 16:38:16+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,28000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 16:38:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,14570000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 16:38:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,7442000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 16:38:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.96
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 16:38:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,7508000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 16:38:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.94
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 16:38:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,7433700000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 16:38:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.96
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 16:38:16+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.88
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,41806000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,41806000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7430000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7430000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,34376000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11124000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5549000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3906000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,3283000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1093000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24955000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9421000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9421000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1708000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7713000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,564000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8277000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,22000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3YTD,2012-01-01,2012-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8255000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3YTD,2012-01-01,2012-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,7436000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3YTD,2012-01-01,2012-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.11
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3YTD,2012-01-01,2012-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,7508000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3YTD,2012-01-01,2012-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.1
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3YTD,2012-01-01,2012-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,7460500000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3YTD,2012-01-01,2012-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.11
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3YTD,2012-01-01,2012-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.66
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3TTM,2011-10-03,2012-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,53245000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3TTM,2011-10-03,2012-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,53245000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3TTM,2011-10-03,2012-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9257000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3TTM,2011-10-03,2012-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9257000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3TTM,2011-10-03,2012-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,43988000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3TTM,2011-10-03,2012-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14945000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3TTM,2011-10-03,2012-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7732000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3TTM,2011-10-03,2012-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,5222000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3TTM,2011-10-03,2012-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,3972000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3TTM,2011-10-03,2012-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1472000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3TTM,2011-10-03,2012-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,33343000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3TTM,2011-10-03,2012-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10645000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3TTM,2011-10-03,2012-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,10645000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3TTM,2011-10-03,2012-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2142000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3TTM,2011-10-03,2012-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8503000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3TTM,2011-10-03,2012-09-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,1222000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3TTM,2011-10-03,2012-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,9725000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3TTM,2011-10-03,2012-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,31000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3TTM,2011-10-03,2012-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,9694000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3TTM,2011-10-03,2012-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,7436000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3TTM,2011-10-03,2012-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.3
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3TTM,2011-10-03,2012-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,7508000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3TTM,2011-10-03,2012-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.28
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3TTM,2011-10-03,2012-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,7460500000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3TTM,2011-10-03,2012-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.3
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3TTM,2011-10-03,2012-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.86
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3,2012-07-02,2012-09-30,2013-11-08 15:43:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12953000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3,2012-07-02,2012-09-30,2013-11-08 15:43:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12953000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3,2012-07-02,2012-09-30,2013-11-08 15:43:52+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2309000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3,2012-07-02,2012-09-30,2013-11-08 15:43:52+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2309000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3,2012-07-02,2012-09-30,2013-11-08 15:43:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10644000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3,2012-07-02,2012-09-30,2013-11-08 15:43:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3491000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3,2012-07-02,2012-09-30,2013-11-08 15:43:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1887000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3,2012-07-02,2012-09-30,2013-11-08 15:43:52+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1211000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3,2012-07-02,2012-09-30,2013-11-08 15:43:52+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,937000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3,2012-07-02,2012-09-30,2013-11-08 15:43:52+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,312000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3,2012-07-02,2012-09-30,2013-11-08 15:43:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7838000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3,2012-07-02,2012-09-30,2013-11-08 15:43:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2806000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3,2012-07-02,2012-09-30,2013-11-08 15:43:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2806000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3,2012-07-02,2012-09-30,2013-11-08 15:43:52+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-183000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3,2012-07-02,2012-09-30,2013-11-08 15:43:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2989000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3,2012-07-02,2012-09-30,2013-11-08 15:43:52+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,225000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3,2012-07-02,2012-09-30,2013-11-08 15:43:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3214000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3,2012-07-02,2012-09-30,2013-11-08 15:43:52+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,6000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3,2012-07-02,2012-09-30,2013-11-08 15:43:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3208000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3,2012-07-02,2012-09-30,2013-11-08 15:43:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,7436000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3,2012-07-02,2012-09-30,2013-11-08 15:43:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.43
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3,2012-07-02,2012-09-30,2013-11-08 15:43:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,7508000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3,2012-07-02,2012-09-30,2013-11-08 15:43:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.43
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3,2012-07-02,2012-09-30,2013-11-08 15:43:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,7460500000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3,2012-07-02,2012-09-30,2013-11-08 15:43:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.43
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q3,2012-07-02,2012-09-30,2013-11-08 15:43:52+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.22
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2YTD,2012-01-01,2012-07-01,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,28853000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2YTD,2012-01-01,2012-07-01,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,28853000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2YTD,2012-01-01,2012-07-01,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5121000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2YTD,2012-01-01,2012-07-01,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5121000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2YTD,2012-01-01,2012-07-01,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,23732000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2YTD,2012-01-01,2012-07-01,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7633000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2YTD,2012-01-01,2012-07-01,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3662000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2YTD,2012-01-01,2012-07-01,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,2695000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2YTD,2012-01-01,2012-07-01,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2346000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2YTD,2012-01-01,2012-07-01,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,781000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2YTD,2012-01-01,2012-07-01,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17117000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2YTD,2012-01-01,2012-07-01,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6615000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2YTD,2012-01-01,2012-07-01,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6615000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2YTD,2012-01-01,2012-07-01,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1891000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2YTD,2012-01-01,2012-07-01,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4724000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2YTD,2012-01-01,2012-07-01,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,339000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2YTD,2012-01-01,2012-07-01,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5063000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2YTD,2012-01-01,2012-07-01,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,16000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2YTD,2012-01-01,2012-07-01,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5047000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2YTD,2012-01-01,2012-07-01,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,7476000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2YTD,2012-01-01,2012-07-01,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.68
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2YTD,2012-01-01,2012-07-01,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,7537000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2YTD,2012-01-01,2012-07-01,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.67
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2YTD,2012-01-01,2012-07-01,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,7393200000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2YTD,2012-01-01,2012-07-01,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.68
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2YTD,2012-01-01,2012-07-01,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.44
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2TTM,2011-07-04,2012-07-01,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,56901000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2TTM,2011-07-04,2012-07-01,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,56901000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2TTM,2011-07-04,2012-07-01,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,10357000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2TTM,2011-07-04,2012-07-01,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,10357000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2TTM,2011-07-04,2012-07-01,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,46544000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2TTM,2011-07-04,2012-07-01,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15911000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2TTM,2011-07-04,2012-07-01,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8021000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2TTM,2011-07-04,2012-07-01,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,5400000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2TTM,2011-07-04,2012-07-01,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,3582000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2TTM,2011-07-04,2012-07-01,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2250000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2TTM,2011-07-04,2012-07-01,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,35164000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2TTM,2011-07-04,2012-07-01,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,11380000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2TTM,2011-07-04,2012-07-01,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,11380000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2TTM,2011-07-04,2012-07-01,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3541000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2TTM,2011-07-04,2012-07-01,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7839000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2TTM,2011-07-04,2012-07-01,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,2421000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2TTM,2011-07-04,2012-07-01,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,10260000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2TTM,2011-07-04,2012-07-01,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,36000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2TTM,2011-07-04,2012-07-01,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,10224000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2TTM,2011-07-04,2012-07-01,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,7476000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2TTM,2011-07-04,2012-07-01,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.35
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2TTM,2011-07-04,2012-07-01,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,7537000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2TTM,2011-07-04,2012-07-01,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.33
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2TTM,2011-07-04,2012-07-01,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,7393200000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2TTM,2011-07-04,2012-07-01,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.35
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2TTM,2011-07-04,2012-07-01,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.84
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2,2012-04-02,2012-07-01,2013-08-09 16:59:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13968000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2,2012-04-02,2012-07-01,2013-08-09 16:59:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13968000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2,2012-04-02,2012-07-01,2013-08-09 16:59:14+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2376000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2,2012-04-02,2012-07-01,2013-08-09 16:59:14+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2376000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2,2012-04-02,2012-07-01,2013-08-09 16:59:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11592000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2,2012-04-02,2012-07-01,2013-08-09 16:59:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3665000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2,2012-04-02,2012-07-01,2013-08-09 16:59:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1600000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2,2012-04-02,2012-07-01,2013-08-09 16:59:14+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1275000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2,2012-04-02,2012-07-01,2013-08-09 16:59:14+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,688000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2,2012-04-02,2012-07-01,2013-08-09 16:59:14+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,184000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2,2012-04-02,2012-07-01,2013-08-09 16:59:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7412000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2,2012-04-02,2012-07-01,2013-08-09 16:59:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4180000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2,2012-04-02,2012-07-01,2013-08-09 16:59:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4180000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2,2012-04-02,2012-07-01,2013-08-09 16:59:14+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1180000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2,2012-04-02,2012-07-01,2013-08-09 16:59:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3000000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2,2012-04-02,2012-07-01,2013-08-09 16:59:14+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,260000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2,2012-04-02,2012-07-01,2013-08-09 16:59:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3260000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2,2012-04-02,2012-07-01,2013-08-09 16:59:14+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,7000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2,2012-04-02,2012-07-01,2013-08-09 16:59:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3253000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2,2012-04-02,2012-07-01,2013-08-09 16:59:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,7476000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2,2012-04-02,2012-07-01,2013-08-09 16:59:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.44
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2,2012-04-02,2012-07-01,2013-08-09 16:59:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,7537000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2,2012-04-02,2012-07-01,2013-08-09 16:59:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.43
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2,2012-04-02,2012-07-01,2013-08-09 16:59:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,7393200000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2,2012-04-02,2012-07-01,2013-08-09 16:59:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.44
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q2,2012-04-02,2012-07-01,2013-08-09 16:59:14+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.22
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1TTM,2011-04-04,2012-04-01,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,59418000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1TTM,2011-04-04,2012-04-01,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,59418000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1TTM,2011-04-04,2012-04-01,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,11552000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1TTM,2011-04-04,2012-04-01,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,11552000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1TTM,2011-04-04,2012-04-01,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,47866000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1TTM,2011-04-04,2012-04-01,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,17046000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1TTM,2011-04-04,2012-04-01,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8652000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1TTM,2011-04-04,2012-04-01,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,5509000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1TTM,2011-04-04,2012-04-01,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,3317000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1TTM,2011-04-04,2012-04-01,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2544000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1TTM,2011-04-04,2012-04-01,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,37068000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1TTM,2011-04-04,2012-04-01,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10798000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1TTM,2011-04-04,2012-04-01,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,10798000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1TTM,2011-04-04,2012-04-01,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3438000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1TTM,2011-04-04,2012-04-01,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7360000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1TTM,2011-04-04,2012-04-01,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,2258000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1TTM,2011-04-04,2012-04-01,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,9618000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1TTM,2011-04-04,2012-04-01,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,37000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1TTM,2011-04-04,2012-04-01,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,9581000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1TTM,2011-04-04,2012-04-01,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,7537000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1TTM,2011-04-04,2012-04-01,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.24
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1TTM,2011-04-04,2012-04-01,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,7598000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1TTM,2011-04-04,2012-04-01,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.23
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1TTM,2011-04-04,2012-04-01,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,7475000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1TTM,2011-04-04,2012-04-01,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.24
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1TTM,2011-04-04,2012-04-01,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.82
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1,2012-01-01,2012-04-01,2013-05-09 20:03:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14885000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1,2012-01-01,2012-04-01,2013-05-09 20:03:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14885000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1,2012-01-01,2012-04-01,2013-05-09 20:03:04+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2745000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1,2012-01-01,2012-04-01,2013-05-09 20:03:04+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2745000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1,2012-01-01,2012-04-01,2013-05-09 20:03:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12140000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1,2012-01-01,2012-04-01,2013-05-09 20:03:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3968000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1,2012-01-01,2012-04-01,2013-05-09 20:03:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2062000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1,2012-01-01,2012-04-01,2013-05-09 20:03:04+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1420000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1,2012-01-01,2012-04-01,2013-05-09 20:03:04+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1658000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1,2012-01-01,2012-04-01,2013-05-09 20:03:04+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,597000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1,2012-01-01,2012-04-01,2013-05-09 20:03:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9705000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1,2012-01-01,2012-04-01,2013-05-09 20:03:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2435000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1,2012-01-01,2012-04-01,2013-05-09 20:03:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2435000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1,2012-01-01,2012-04-01,2013-05-09 20:03:04+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,711000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1,2012-01-01,2012-04-01,2013-05-09 20:03:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1724000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1,2012-01-01,2012-04-01,2013-05-09 20:03:04+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,79000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1,2012-01-01,2012-04-01,2013-05-09 20:03:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1803000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1,2012-01-01,2012-04-01,2013-05-09 20:03:04+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,9000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1,2012-01-01,2012-04-01,2013-05-09 20:03:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1794000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1,2012-01-01,2012-04-01,2013-05-09 20:03:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,7537000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1,2012-01-01,2012-04-01,2013-05-09 20:03:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.24
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1,2012-01-01,2012-04-01,2013-05-09 20:03:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,7598000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1,2012-01-01,2012-04-01,2013-05-09 20:03:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.24
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1,2012-01-01,2012-04-01,2013-05-09 20:03:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,7475000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1,2012-01-01,2012-04-01,2013-05-09 20:03:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.24
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2012.0,Q1,2012-01-01,2012-04-01,2013-05-09 20:03:04+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.22
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q4,2013-09-30,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13558000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q4,2013-09-30,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13558000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q4,2013-09-30,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2794000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q4,2013-09-30,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2794000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q4,2013-09-30,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10764000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q4,2013-09-30,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4152000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q4,2013-09-30,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1811000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q4,2013-09-30,2013-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1123000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q4,2013-09-30,2013-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,925000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q4,2013-09-30,2013-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,635000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q4,2013-09-30,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8646000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q4,2013-09-30,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2118000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q4,2013-09-30,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,943000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q4,2013-09-30,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,943000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q4,2013-09-30,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3061000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q4,2013-09-30,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,430000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q4,2013-09-30,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2631000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q4,2013-09-30,2013-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-57000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q4,2013-09-30,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2574000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q4,2013-09-30,2013-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,6000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q4,2013-09-30,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2568000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q4,2013-09-30,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6813000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q4,2013-09-30,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.46
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q4,2013-09-30,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6895000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q4,2013-09-30,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.44
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q4,2013-09-30,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6812100000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q4,2013-09-30,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.46
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q4,2013-09-30,2013-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.24
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 16:38:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,51584000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 16:38:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,51584000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 16:38:16+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9586000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 16:38:16+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9586000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 16:38:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,41998000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 16:38:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14355000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 16:38:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6678000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 16:38:16+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4599000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 16:38:16+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1182000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 16:38:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26814000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 16:38:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,15184000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 16:38:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,532000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 16:38:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,532000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 16:38:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,15716000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 16:38:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4306000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 16:38:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11410000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 16:38:16+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,10662000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 16:38:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,22072000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 16:38:16+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,69000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 16:38:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,22003000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 16:38:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6813000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 16:38:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.23
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 16:38:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6895000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 16:38:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.19
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 16:38:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6812100000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 16:38:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.23
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 16:38:16+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.96
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3,2013-07-01,2013-09-29,2014-11-06 17:03:56+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12643000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3,2013-07-01,2013-09-29,2014-11-06 17:03:56+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12643000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3,2013-07-01,2013-09-29,2014-11-06 17:03:56+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2287000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3,2013-07-01,2013-09-29,2014-11-06 17:03:56+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2287000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3,2013-07-01,2013-09-29,2014-11-06 17:03:56+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10356000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3,2013-07-01,2013-09-29,2014-11-06 17:03:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3395000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3,2013-07-01,2013-09-29,2014-11-06 17:03:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1627000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3,2013-07-01,2013-09-29,2014-11-06 17:03:56+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1117000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3,2013-07-01,2013-09-29,2014-11-06 17:03:56+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,233000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3,2013-07-01,2013-09-29,2014-11-06 17:03:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6372000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3,2013-07-01,2013-09-29,2014-11-06 17:03:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3984000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3,2013-07-01,2013-09-29,2014-11-06 17:03:56+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-411000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3,2013-07-01,2013-09-29,2014-11-06 17:03:56+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-411000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3,2013-07-01,2013-09-29,2014-11-06 17:03:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3573000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3,2013-07-01,2013-09-29,2014-11-06 17:03:56+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,985000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3,2013-07-01,2013-09-29,2014-11-06 17:03:56+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2588000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3,2013-07-01,2013-09-29,2014-11-06 17:03:56+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,11000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3,2013-07-01,2013-09-29,2014-11-06 17:03:56+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2599000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3,2013-07-01,2013-09-29,2014-11-06 17:03:56+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,9000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3,2013-07-01,2013-09-29,2014-11-06 17:03:56+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2590000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3,2013-07-01,2013-09-29,2014-11-06 17:03:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6581000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3,2013-07-01,2013-09-29,2014-11-06 17:03:56+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.39
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3,2013-07-01,2013-09-29,2014-11-06 17:03:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6656000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3,2013-07-01,2013-09-29,2014-11-06 17:03:56+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.39
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3,2013-07-01,2013-09-29,2014-11-06 17:03:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6641000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3,2013-07-01,2013-09-29,2014-11-06 17:03:56+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.39
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3,2013-07-01,2013-09-29,2014-11-06 17:03:56+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.24
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3YTD,2013-01-01,2013-09-29,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,38026000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3YTD,2013-01-01,2013-09-29,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,38026000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3YTD,2013-01-01,2013-09-29,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6792000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3YTD,2013-01-01,2013-09-29,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6792000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3YTD,2013-01-01,2013-09-29,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,31234000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3YTD,2013-01-01,2013-09-29,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10203000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3YTD,2013-01-01,2013-09-29,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4867000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3YTD,2013-01-01,2013-09-29,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3476000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3YTD,2013-01-01,2013-09-29,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-925000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3YTD,2013-01-01,2013-09-29,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,547000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3YTD,2013-01-01,2013-09-29,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18168000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3YTD,2013-01-01,2013-09-29,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,13066000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3YTD,2013-01-01,2013-09-29,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-411000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3YTD,2013-01-01,2013-09-29,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-411000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3YTD,2013-01-01,2013-09-29,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,12655000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3YTD,2013-01-01,2013-09-29,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3876000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3YTD,2013-01-01,2013-09-29,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8779000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3YTD,2013-01-01,2013-09-29,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,10719000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3YTD,2013-01-01,2013-09-29,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,19498000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3YTD,2013-01-01,2013-09-29,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,63000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3YTD,2013-01-01,2013-09-29,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,19435000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3YTD,2013-01-01,2013-09-29,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6581000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3YTD,2013-01-01,2013-09-29,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.77
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3YTD,2013-01-01,2013-09-29,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6656000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3YTD,2013-01-01,2013-09-29,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.75
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3YTD,2013-01-01,2013-09-29,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6641000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3YTD,2013-01-01,2013-09-29,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.77
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3YTD,2013-01-01,2013-09-29,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.72
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3TTM,2012-10-01,2013-09-29,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,50877000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3TTM,2012-10-01,2013-09-29,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,50877000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3TTM,2012-10-01,2013-09-29,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9183000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3TTM,2012-10-01,2013-09-29,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9183000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3TTM,2012-10-01,2013-09-29,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,41694000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3TTM,2012-10-01,2013-09-29,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14250000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3TTM,2012-10-01,2013-09-29,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6800000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3TTM,2012-10-01,2013-09-29,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4679000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3TTM,2012-10-01,2013-09-29,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-4208000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3TTM,2012-10-01,2013-09-29,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1264000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3TTM,2012-10-01,2013-09-29,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22785000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3TTM,2012-10-01,2013-09-29,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,18909000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3TTM,2012-10-01,2013-09-29,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4433000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3TTM,2012-10-01,2013-09-29,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4433000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3TTM,2012-10-01,2013-09-29,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,14476000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3TTM,2012-10-01,2013-09-29,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4389000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3TTM,2012-10-01,2013-09-29,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10087000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3TTM,2012-10-01,2013-09-29,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,15732000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3TTM,2012-10-01,2013-09-29,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,25819000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3TTM,2012-10-01,2013-09-29,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,69000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3TTM,2012-10-01,2013-09-29,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,25750000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3TTM,2012-10-01,2013-09-29,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6581000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3TTM,2012-10-01,2013-09-29,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.62
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3TTM,2012-10-01,2013-09-29,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6656000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3TTM,2012-10-01,2013-09-29,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.59
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3TTM,2012-10-01,2013-09-29,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6641000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3TTM,2012-10-01,2013-09-29,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.62
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q3TTM,2012-10-01,2013-09-29,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.94
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,25383000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,25383000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4505000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4505000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,20878000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6808000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3240000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,2359000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-925000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,314000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11796000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9082000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9082000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2891000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6191000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,10708000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,16899000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,54000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2YTD,2013-01-01,2013-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,16845000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2YTD,2013-01-01,2013-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,7042000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2YTD,2013-01-01,2013-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.38
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2YTD,2013-01-01,2013-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,7117000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2YTD,2013-01-01,2013-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.36
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2YTD,2013-01-01,2013-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,7047500000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2YTD,2013-01-01,2013-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.38
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2YTD,2013-01-01,2013-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.48
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2TTM,2012-07-02,2013-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,51187000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2TTM,2012-07-02,2013-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,51187000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2TTM,2012-07-02,2013-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9205000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2TTM,2012-07-02,2013-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9205000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2TTM,2012-07-02,2013-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,41982000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2TTM,2012-07-02,2013-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14346000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2TTM,2012-07-02,2013-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7060000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2TTM,2012-07-02,2013-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4773000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2TTM,2012-07-02,2013-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-3271000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2TTM,2012-07-02,2013-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1343000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2TTM,2012-07-02,2013-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24251000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2TTM,2012-07-02,2013-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,17731000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2TTM,2012-07-02,2013-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4022000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2TTM,2012-07-02,2013-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4022000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2TTM,2012-07-02,2013-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,13709000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2TTM,2012-07-02,2013-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3221000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2TTM,2012-07-02,2013-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10488000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2TTM,2012-07-02,2013-06-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,15946000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2TTM,2012-07-02,2013-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,26434000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2TTM,2012-07-02,2013-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,66000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2TTM,2012-07-02,2013-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,26368000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2TTM,2012-07-02,2013-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,7042000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2TTM,2012-07-02,2013-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.66
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2TTM,2012-07-02,2013-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,7117000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2TTM,2012-07-02,2013-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.63
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2TTM,2012-07-02,2013-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,7047500000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2TTM,2012-07-02,2013-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.66
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2TTM,2012-07-02,2013-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.92
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:56:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12973000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:56:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12973000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:56:04+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2242000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:56:04+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2242000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:56:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10731000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:56:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3591000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:56:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1530000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:56:04+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1140000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:56:04+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-1070000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:56:04+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,183000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:56:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5374000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:56:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5357000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:56:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5357000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:56:04+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1782000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:56:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3575000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:56:04+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,10559000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:56:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,14134000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:56:04+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,39000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:56:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,14095000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:56:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,7042000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:56:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:56:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,7117000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:56:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.98
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:56:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,7047500000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:56:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:56:04+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.24
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:17:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12410000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:17:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12410000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:17:01+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2263000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:17:01+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2263000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:17:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10147000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:17:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3217000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:17:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1710000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:17:01+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1219000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:17:01+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,145000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:17:01+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,131000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:17:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6422000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:17:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3725000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:17:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3725000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:17:01+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1109000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:17:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2616000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:17:01+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,149000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:17:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2765000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:17:01+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,15000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:17:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2750000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:17:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,7187000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:17:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.38
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:17:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,7269000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:17:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.38
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:17:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,7236800000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:17:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.38
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 17:17:01+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.24
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1TTM,2012-04-02,2013-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,52182000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1TTM,2012-04-02,2013-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,52182000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1TTM,2012-04-02,2013-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9339000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1TTM,2012-04-02,2013-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9339000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1TTM,2012-04-02,2013-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,42843000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1TTM,2012-04-02,2013-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14420000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1TTM,2012-04-02,2013-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7130000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1TTM,2012-04-02,2013-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4908000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1TTM,2012-04-02,2013-03-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-1513000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1TTM,2012-04-02,2013-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1344000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1TTM,2012-04-02,2013-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26289000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1TTM,2012-04-02,2013-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,16554000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1TTM,2012-04-02,2013-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4022000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1TTM,2012-04-02,2013-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4022000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1TTM,2012-04-02,2013-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,12532000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1TTM,2012-04-02,2013-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2619000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1TTM,2012-04-02,2013-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9913000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1TTM,2012-04-02,2013-03-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,5647000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1TTM,2012-04-02,2013-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,15560000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1TTM,2012-04-02,2013-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,34000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1TTM,2012-04-02,2013-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,15526000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1TTM,2012-04-02,2013-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,7187000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1TTM,2012-04-02,2013-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.1
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1TTM,2012-04-02,2013-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,7269000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1TTM,2012-04-02,2013-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.08
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1TTM,2012-04-02,2013-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,7236800000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1TTM,2012-04-02,2013-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.1
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2013.0,Q1TTM,2012-04-02,2013-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.9
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q4,2014-09-29,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13118000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q4,2014-09-29,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13118000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q4,2014-09-29,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2702000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q4,2014-09-29,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2702000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q4,2014-09-29,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10416000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q4,2014-09-29,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3981000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q4,2014-09-29,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3209000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q4,2014-09-29,2014-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,949000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q4,2014-09-29,2014-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,130000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q4,2014-09-29,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8269000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q4,2014-09-29,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2147000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q4,2014-09-29,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-345000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q4,2014-09-29,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-345000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q4,2014-09-29,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1803000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q4,2014-09-29,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,545000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q4,2014-09-29,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1257000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q4,2014-09-29,2014-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-73000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q4,2014-09-29,2014-12-31,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,49000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q4,2014-09-29,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1237000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q4,2014-09-29,2014-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,8000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q4,2014-09-29,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1228000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q4,2014-09-29,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6346000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q4,2014-09-29,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.2
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q4,2014-09-29,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6424000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q4,2014-09-29,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.19
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q4,2014-09-29,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6343800000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q4,2014-09-29,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.2
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q4,2014-09-29,2014-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.26
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3,2014-06-30,2014-09-28,2015-11-05 17:15:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12361000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3,2014-06-30,2014-09-28,2015-11-05 17:15:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12361000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3,2014-06-30,2014-09-28,2015-11-05 17:15:15+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2368000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3,2014-06-30,2014-09-28,2015-11-05 17:15:15+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2368000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3,2014-06-30,2014-09-28,2015-11-05 17:15:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9993000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3,2014-06-30,2014-09-28,2015-11-05 17:15:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3556000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3,2014-06-30,2014-09-28,2015-11-05 17:15:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1802000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3,2014-06-30,2014-09-28,2015-11-05 17:15:15+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,972000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3,2014-06-30,2014-09-28,2015-11-05 17:15:15+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-19000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3,2014-06-30,2014-09-28,2015-11-05 17:15:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6311000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3,2014-06-30,2014-09-28,2015-11-05 17:15:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3682000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3,2014-06-30,2014-09-28,2015-11-05 17:15:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-94000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3,2014-06-30,2014-09-28,2015-11-05 17:15:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-94000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3,2014-06-30,2014-09-28,2015-11-05 17:15:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3587000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3,2014-06-30,2014-09-28,2015-11-05 17:15:15+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,911000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3,2014-06-30,2014-09-28,2015-11-05 17:15:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2676000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3,2014-06-30,2014-09-28,2015-11-05 17:15:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2672000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3,2014-06-30,2014-09-28,2015-11-05 17:15:15+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,6000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3,2014-06-30,2014-09-28,2015-11-05 17:15:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2666000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3,2014-06-30,2014-09-28,2015-11-05 17:15:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6330000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3,2014-06-30,2014-09-28,2015-11-05 17:15:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.42
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3,2014-06-30,2014-09-28,2015-11-05 17:15:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6403000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3,2014-06-30,2014-09-28,2015-11-05 17:15:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.42
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3,2014-06-30,2014-09-28,2015-11-05 17:15:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6347600000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3,2014-06-30,2014-09-28,2015-11-05 17:15:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.42
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3,2014-06-30,2014-09-28,2015-11-05 17:15:15+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.26
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3YTD,2014-01-01,2014-09-28,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,36487000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3YTD,2014-01-01,2014-09-28,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,36487000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3YTD,2014-01-01,2014-09-28,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6875000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3YTD,2014-01-01,2014-09-28,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6875000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3YTD,2014-01-01,2014-09-28,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,29612000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3YTD,2014-01-01,2014-09-28,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10116000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3YTD,2014-01-01,2014-09-28,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5184000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3YTD,2014-01-01,2014-09-28,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3090000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3YTD,2014-01-01,2014-09-28,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,120000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3YTD,2014-01-01,2014-09-28,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18510000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3YTD,2014-01-01,2014-09-28,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,11102000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3YTD,2014-01-01,2014-09-28,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-664000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3YTD,2014-01-01,2014-09-28,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-664000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3YTD,2014-01-01,2014-09-28,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,10437000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3YTD,2014-01-01,2014-09-28,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2575000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3YTD,2014-01-01,2014-09-28,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7862000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3YTD,2014-01-01,2014-09-28,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,73000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3YTD,2014-01-01,2014-09-28,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7931000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3YTD,2014-01-01,2014-09-28,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,24000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3YTD,2014-01-01,2014-09-28,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7907000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3YTD,2014-01-01,2014-09-28,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6330000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3YTD,2014-01-01,2014-09-28,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.24
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3YTD,2014-01-01,2014-09-28,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6403000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3YTD,2014-01-01,2014-09-28,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.23
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3YTD,2014-01-01,2014-09-28,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6347600000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3YTD,2014-01-01,2014-09-28,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.24
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3YTD,2014-01-01,2014-09-28,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.78
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3TTM,2013-09-30,2014-09-28,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,50045000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3TTM,2013-09-30,2014-09-28,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,50045000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3TTM,2013-09-30,2014-09-28,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9669000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3TTM,2013-09-30,2014-09-28,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9669000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3TTM,2013-09-30,2014-09-28,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,40376000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3TTM,2013-09-30,2014-09-28,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14268000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3TTM,2013-09-30,2014-09-28,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6995000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3TTM,2013-09-30,2014-09-28,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4213000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3TTM,2013-09-30,2014-09-28,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,925000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3TTM,2013-09-30,2014-09-28,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,755000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3TTM,2013-09-30,2014-09-28,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27156000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3TTM,2013-09-30,2014-09-28,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,13220000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3TTM,2013-09-30,2014-09-28,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,279000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3TTM,2013-09-30,2014-09-28,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,279000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3TTM,2013-09-30,2014-09-28,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,13498000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3TTM,2013-09-30,2014-09-28,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3005000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3TTM,2013-09-30,2014-09-28,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10493000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3TTM,2013-09-30,2014-09-28,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,16000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3TTM,2013-09-30,2014-09-28,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,10505000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3TTM,2013-09-30,2014-09-28,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,30000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3TTM,2013-09-30,2014-09-28,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,10475000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3TTM,2013-09-30,2014-09-28,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6330000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3TTM,2013-09-30,2014-09-28,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.7
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3TTM,2013-09-30,2014-09-28,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6403000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3TTM,2013-09-30,2014-09-28,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.67
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3TTM,2013-09-30,2014-09-28,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6347600000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3TTM,2013-09-30,2014-09-28,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.7
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q3TTM,2013-09-30,2014-09-28,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.02
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2,2014-03-31,2014-06-29,2015-08-06 16:29:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12773000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2,2014-03-31,2014-06-29,2015-08-06 16:29:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12773000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2,2014-03-31,2014-06-29,2015-08-06 16:29:04+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2462000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2,2014-03-31,2014-06-29,2015-08-06 16:29:04+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2462000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2,2014-03-31,2014-06-29,2015-08-06 16:29:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10311000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2,2014-03-31,2014-06-29,2015-08-06 16:29:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3520000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2,2014-03-31,2014-06-29,2015-08-06 16:29:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1759000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2,2014-03-31,2014-06-29,2015-08-06 16:29:04+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1001000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2,2014-03-31,2014-06-29,2015-08-06 16:29:04+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,81000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2,2014-03-31,2014-06-29,2015-08-06 16:29:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6361000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2,2014-03-31,2014-06-29,2015-08-06 16:29:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3950000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2,2014-03-31,2014-06-29,2015-08-06 16:29:04+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,53000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2,2014-03-31,2014-06-29,2015-08-06 16:29:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,53000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2,2014-03-31,2014-06-29,2015-08-06 16:29:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4003000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2,2014-03-31,2014-06-29,2015-08-06 16:29:04+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1082000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2,2014-03-31,2014-06-29,2015-08-06 16:29:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2921000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2,2014-03-31,2014-06-29,2015-08-06 16:29:04+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2,2014-03-31,2014-06-29,2015-08-06 16:29:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2921000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2,2014-03-31,2014-06-29,2015-08-06 16:29:04+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,9000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2,2014-03-31,2014-06-29,2015-08-06 16:29:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2912000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2,2014-03-31,2014-06-29,2015-08-06 16:29:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6368000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2,2014-03-31,2014-06-29,2015-08-06 16:29:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.46
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2,2014-03-31,2014-06-29,2015-08-06 16:29:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6444000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2,2014-03-31,2014-06-29,2015-08-06 16:29:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.45
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2,2014-03-31,2014-06-29,2015-08-06 16:29:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6330400000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2,2014-03-31,2014-06-29,2015-08-06 16:29:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.46
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2,2014-03-31,2014-06-29,2015-08-06 16:29:04+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.26
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2YTD,2014-01-01,2014-06-29,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,24126000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2YTD,2014-01-01,2014-06-29,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,24126000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2YTD,2014-01-01,2014-06-29,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4507000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2YTD,2014-01-01,2014-06-29,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4507000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2YTD,2014-01-01,2014-06-29,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,19619000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2YTD,2014-01-01,2014-06-29,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6560000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2YTD,2014-01-01,2014-06-29,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3382000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2YTD,2014-01-01,2014-06-29,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,2118000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2YTD,2014-01-01,2014-06-29,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,139000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2YTD,2014-01-01,2014-06-29,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12199000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2YTD,2014-01-01,2014-06-29,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7420000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2YTD,2014-01-01,2014-06-29,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-570000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2YTD,2014-01-01,2014-06-29,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-570000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2YTD,2014-01-01,2014-06-29,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6850000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2YTD,2014-01-01,2014-06-29,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1664000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2YTD,2014-01-01,2014-06-29,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5186000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2YTD,2014-01-01,2014-06-29,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,73000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2YTD,2014-01-01,2014-06-29,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5259000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2YTD,2014-01-01,2014-06-29,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,18000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2YTD,2014-01-01,2014-06-29,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5241000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2YTD,2014-01-01,2014-06-29,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6368000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2YTD,2014-01-01,2014-06-29,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.82
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2YTD,2014-01-01,2014-06-29,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6444000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2YTD,2014-01-01,2014-06-29,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.81
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2YTD,2014-01-01,2014-06-29,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6330400000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2YTD,2014-01-01,2014-06-29,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.82
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2YTD,2014-01-01,2014-06-29,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.52
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2TTM,2013-07-01,2014-06-29,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,50327000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2TTM,2013-07-01,2014-06-29,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,50327000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2TTM,2013-07-01,2014-06-29,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9588000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2TTM,2013-07-01,2014-06-29,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9588000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2TTM,2013-07-01,2014-06-29,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,40739000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2TTM,2013-07-01,2014-06-29,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14107000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2TTM,2013-07-01,2014-06-29,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6820000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2TTM,2013-07-01,2014-06-29,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4358000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2TTM,2013-07-01,2014-06-29,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,925000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2TTM,2013-07-01,2014-06-29,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1007000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2TTM,2013-07-01,2014-06-29,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27217000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2TTM,2013-07-01,2014-06-29,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,13522000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2TTM,2013-07-01,2014-06-29,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-38000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2TTM,2013-07-01,2014-06-29,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-38000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2TTM,2013-07-01,2014-06-29,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,13484000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2TTM,2013-07-01,2014-06-29,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3079000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2TTM,2013-07-01,2014-06-29,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10405000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2TTM,2013-07-01,2014-06-29,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,27000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2TTM,2013-07-01,2014-06-29,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,10432000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2TTM,2013-07-01,2014-06-29,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,33000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2TTM,2013-07-01,2014-06-29,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,10399000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2TTM,2013-07-01,2014-06-29,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6368000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2TTM,2013-07-01,2014-06-29,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.67
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2TTM,2013-07-01,2014-06-29,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6444000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2TTM,2013-07-01,2014-06-29,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.64
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2TTM,2013-07-01,2014-06-29,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6330400000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2TTM,2013-07-01,2014-06-29,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.67
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q2TTM,2013-07-01,2014-06-29,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1,2014-01-01,2014-03-30,2015-05-07 15:26:29+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11353000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1,2014-01-01,2014-03-30,2015-05-07 15:26:29+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11353000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1,2014-01-01,2014-03-30,2015-05-07 15:26:29+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2045000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1,2014-01-01,2014-03-30,2015-05-07 15:26:29+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2045000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1,2014-01-01,2014-03-30,2015-05-07 15:26:29+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9308000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1,2014-01-01,2014-03-30,2015-05-07 15:26:29+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3040000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1,2014-01-01,2014-03-30,2015-05-07 15:26:29+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1623000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1,2014-01-01,2014-03-30,2015-05-07 15:26:29+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1117000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1,2014-01-01,2014-03-30,2015-05-07 15:26:29+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,58000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1,2014-01-01,2014-03-30,2015-05-07 15:26:29+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5838000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1,2014-01-01,2014-03-30,2015-05-07 15:26:29+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3470000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1,2014-01-01,2014-03-30,2015-05-07 15:26:29+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-623000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1,2014-01-01,2014-03-30,2015-05-07 15:26:29+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-623000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1,2014-01-01,2014-03-30,2015-05-07 15:26:29+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2847000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1,2014-01-01,2014-03-30,2015-05-07 15:26:29+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,582000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1,2014-01-01,2014-03-30,2015-05-07 15:26:29+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2265000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1,2014-01-01,2014-03-30,2015-05-07 15:26:29+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,73000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1,2014-01-01,2014-03-30,2015-05-07 15:26:29+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2338000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1,2014-01-01,2014-03-30,2015-05-07 15:26:29+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,9000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1,2014-01-01,2014-03-30,2015-05-07 15:26:29+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2329000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1,2014-01-01,2014-03-30,2015-05-07 15:26:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6389000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1,2014-01-01,2014-03-30,2015-05-07 15:26:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.36
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1,2014-01-01,2014-03-30,2015-05-07 15:26:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6476000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1,2014-01-01,2014-03-30,2015-05-07 15:26:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.36
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1,2014-01-01,2014-03-30,2015-05-07 15:26:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6469400000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1,2014-01-01,2014-03-30,2015-05-07 15:26:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.36
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1,2014-01-01,2014-03-30,2015-05-07 15:26:29+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.26
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1TTM,2013-04-01,2014-03-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,50527000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1TTM,2013-04-01,2014-03-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,50527000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1TTM,2013-04-01,2014-03-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9368000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1TTM,2013-04-01,2014-03-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9368000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1TTM,2013-04-01,2014-03-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,41159000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1TTM,2013-04-01,2014-03-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14178000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1TTM,2013-04-01,2014-03-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6591000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1TTM,2013-04-01,2014-03-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4497000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1TTM,2013-04-01,2014-03-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-145000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1TTM,2013-04-01,2014-03-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1109000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1TTM,2013-04-01,2014-03-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26230000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1TTM,2013-04-01,2014-03-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,14929000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1TTM,2013-04-01,2014-03-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-91000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1TTM,2013-04-01,2014-03-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-91000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1TTM,2013-04-01,2014-03-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,14838000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1TTM,2013-04-01,2014-03-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3779000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1TTM,2013-04-01,2014-03-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11059000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1TTM,2013-04-01,2014-03-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,10586000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1TTM,2013-04-01,2014-03-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,21645000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1TTM,2013-04-01,2014-03-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,63000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1TTM,2013-04-01,2014-03-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,21582000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1TTM,2013-04-01,2014-03-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6389000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1TTM,2013-04-01,2014-03-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.21
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1TTM,2013-04-01,2014-03-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6476000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1TTM,2013-04-01,2014-03-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.17
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1TTM,2013-04-01,2014-03-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6469400000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1TTM,2013-04-01,2014-03-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.21
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2014.0,Q1TTM,2013-04-01,2014-03-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.98
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,FY,2015-01-01,2015-12-31,2017-02-23 16:30:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,48851000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,FY,2015-01-01,2015-12-31,2017-02-23 16:30:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,48851000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,FY,2015-01-01,2015-12-31,2017-02-23 16:30:32+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9648000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,FY,2015-01-01,2015-12-31,2017-02-23 16:30:32+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9648000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,FY,2015-01-01,2015-12-31,2017-02-23 16:30:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,39203000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,FY,2015-01-01,2015-12-31,2017-02-23 16:30:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14809000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,FY,2015-01-01,2015-12-31,2017-02-23 16:30:32+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7690000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,FY,2015-01-01,2015-12-31,2017-02-23 16:30:32+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3728000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,FY,2015-01-01,2015-12-31,2017-02-23 16:30:32+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1152000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,FY,2015-01-01,2015-12-31,2017-02-23 16:30:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27379000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,FY,2015-01-01,2015-12-31,2017-02-23 16:30:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,11824000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,FY,2015-01-01,2015-12-31,2017-02-23 16:30:32+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2860000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,FY,2015-01-01,2015-12-31,2017-02-23 16:30:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2860000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,FY,2015-01-01,2015-12-31,2017-02-23 16:30:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8965000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,FY,2015-01-01,2015-12-31,2017-02-23 16:30:32+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1990000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,FY,2015-01-01,2015-12-31,2017-02-23 16:30:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6975000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,FY,2015-01-01,2015-12-31,2017-02-23 16:30:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6986000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,FY,2015-01-01,2015-12-31,2017-02-23 16:30:32+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,26000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,FY,2015-01-01,2015-12-31,2017-02-23 16:30:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6960000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,FY,2015-01-01,2015-12-31,2017-02-23 16:30:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6176000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,FY,2015-01-01,2015-12-31,2017-02-23 16:30:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.13
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,FY,2015-01-01,2015-12-31,2017-02-23 16:30:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6257000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,FY,2015-01-01,2015-12-31,2017-02-23 16:30:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.11
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,FY,2015-01-01,2015-12-31,2017-02-23 16:30:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6159300000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,FY,2015-01-01,2015-12-31,2017-02-23 16:30:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.13
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,FY,2015-01-01,2015-12-31,2017-02-23 16:30:32+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.12
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q4,2015-09-28,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14047000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q4,2015-09-28,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14047000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q4,2015-09-28,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3411000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q4,2015-09-28,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3411000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q4,2015-09-28,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10636000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q4,2015-09-28,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5049000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q4,2015-09-28,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2349000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q4,2015-09-28,2015-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,979000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q4,2015-09-28,2015-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,425000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q4,2015-09-28,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8802000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q4,2015-09-28,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1834000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q4,2015-09-28,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2187000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q4,2015-09-28,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2190000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q4,2015-09-28,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-353000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q4,2015-09-28,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-188000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q4,2015-09-28,2015-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-1000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q4,2015-09-28,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-166000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q4,2015-09-28,2015-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-14000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q4,2015-09-28,2015-12-31,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,11000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q4,2015-09-28,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-169000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q4,2015-09-28,2015-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,2000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q4,2015-09-28,2015-12-31,,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,1000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q4,2015-09-28,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-172000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q4,2015-09-28,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6176000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q4,2015-09-28,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.03
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q4,2015-09-28,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6257000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q4,2015-09-28,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.03
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q4,2015-09-28,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6159300000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q4,2015-09-28,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.03
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q4,2015-09-28,2015-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.28
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3,2015-06-29,2015-09-27,2016-11-10 17:15:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12087000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3,2015-06-29,2015-09-27,2016-11-10 17:15:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12087000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3,2015-06-29,2015-09-27,2016-11-10 17:15:16+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2219000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3,2015-06-29,2015-09-27,2016-11-10 17:15:16+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2219000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3,2015-06-29,2015-09-27,2016-11-10 17:15:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9868000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3,2015-06-29,2015-09-27,2016-11-10 17:15:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3270000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3,2015-06-29,2015-09-27,2016-11-10 17:15:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1722000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3,2015-06-29,2015-09-27,2016-11-10 17:15:16+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,937000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3,2015-06-29,2015-09-27,2016-11-10 17:15:16+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,581000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3,2015-06-29,2015-09-27,2016-11-10 17:15:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6510000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3,2015-06-29,2015-09-27,2016-11-10 17:15:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3358000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3,2015-06-29,2015-09-27,2016-11-10 17:15:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-661000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3,2015-06-29,2015-09-27,2016-11-10 17:15:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-661000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3,2015-06-29,2015-09-27,2016-11-10 17:15:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2697000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3,2015-06-29,2015-09-27,2016-11-10 17:15:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,567000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3,2015-06-29,2015-09-27,2016-11-10 17:15:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2130000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3,2015-06-29,2015-09-27,2016-11-10 17:15:16+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,8000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3,2015-06-29,2015-09-27,2016-11-10 17:15:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2139000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3,2015-06-29,2015-09-27,2016-11-10 17:15:16+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,9000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3,2015-06-29,2015-09-27,2016-11-10 17:15:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2130000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3,2015-06-29,2015-09-27,2016-11-10 17:15:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6168000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3,2015-06-29,2015-09-27,2016-11-10 17:15:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.35
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3,2015-06-29,2015-09-27,2016-11-10 17:15:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6243000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3,2015-06-29,2015-09-27,2016-11-10 17:15:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.34
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3,2015-06-29,2015-09-27,2016-11-10 17:15:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6085700000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3,2015-06-29,2015-09-27,2016-11-10 17:15:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.35
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3,2015-06-29,2015-09-27,2016-11-10 17:15:16+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.28
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3YTD,2015-01-01,2015-09-27,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,34804000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3YTD,2015-01-01,2015-09-27,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,34804000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3YTD,2015-01-01,2015-09-27,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6237000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3YTD,2015-01-01,2015-09-27,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6237000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3YTD,2015-01-01,2015-09-27,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,28567000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3YTD,2015-01-01,2015-09-27,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9760000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3YTD,2015-01-01,2015-09-27,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5341000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3YTD,2015-01-01,2015-09-27,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,2749000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3YTD,2015-01-01,2015-09-27,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,727000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3YTD,2015-01-01,2015-09-27,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18577000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3YTD,2015-01-01,2015-09-27,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9990000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3YTD,2015-01-01,2015-09-27,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-670000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3YTD,2015-01-01,2015-09-27,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-670000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3YTD,2015-01-01,2015-09-27,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9318000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3YTD,2015-01-01,2015-09-27,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2178000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3YTD,2015-01-01,2015-09-27,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7141000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3YTD,2015-01-01,2015-09-27,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,14000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3YTD,2015-01-01,2015-09-27,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7155000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3YTD,2015-01-01,2015-09-27,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,24000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3YTD,2015-01-01,2015-09-27,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7132000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3YTD,2015-01-01,2015-09-27,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6168000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3YTD,2015-01-01,2015-09-27,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.16
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3YTD,2015-01-01,2015-09-27,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6243000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3YTD,2015-01-01,2015-09-27,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.14
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3YTD,2015-01-01,2015-09-27,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6085700000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3YTD,2015-01-01,2015-09-27,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.16
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3YTD,2015-01-01,2015-09-27,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.84
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3TTM,2014-09-29,2015-09-27,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,47922000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3TTM,2014-09-29,2015-09-27,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,47922000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3TTM,2014-09-29,2015-09-27,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8939000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3TTM,2014-09-29,2015-09-27,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8939000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3TTM,2014-09-29,2015-09-27,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,38983000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3TTM,2014-09-29,2015-09-27,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,13741000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3TTM,2014-09-29,2015-09-27,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8550000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3TTM,2014-09-29,2015-09-27,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3698000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3TTM,2014-09-29,2015-09-27,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,857000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3TTM,2014-09-29,2015-09-27,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26846000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3TTM,2014-09-29,2015-09-27,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,12137000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3TTM,2014-09-29,2015-09-27,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1015000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3TTM,2014-09-29,2015-09-27,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1015000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3TTM,2014-09-29,2015-09-27,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,11121000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3TTM,2014-09-29,2015-09-27,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2723000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3TTM,2014-09-29,2015-09-27,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8398000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3TTM,2014-09-29,2015-09-27,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-59000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3TTM,2014-09-29,2015-09-27,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,49000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3TTM,2014-09-29,2015-09-27,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8392000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3TTM,2014-09-29,2015-09-27,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,32000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3TTM,2014-09-29,2015-09-27,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8360000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3TTM,2014-09-29,2015-09-27,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6168000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3TTM,2014-09-29,2015-09-27,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.36
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3TTM,2014-09-29,2015-09-27,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6243000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3TTM,2014-09-29,2015-09-27,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.33
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3TTM,2014-09-29,2015-09-27,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6085700000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3TTM,2014-09-29,2015-09-27,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.36
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q3TTM,2014-09-29,2015-09-27,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.1
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2,2015-03-30,2015-06-28,2016-08-11 16:59:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11853000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2,2015-03-30,2015-06-28,2016-08-11 16:59:40+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11853000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2,2015-03-30,2015-06-28,2016-08-11 16:59:40+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2180000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2,2015-03-30,2015-06-28,2016-08-11 16:59:40+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2180000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2,2015-03-30,2015-06-28,2016-08-11 16:59:40+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9673000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2,2015-03-30,2015-06-28,2016-08-11 16:59:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3386000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2,2015-03-30,2015-06-28,2016-08-11 16:59:40+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1734000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2,2015-03-30,2015-06-28,2016-08-11 16:59:40+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,872000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2,2015-03-30,2015-06-28,2016-08-11 16:59:40+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,86000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2,2015-03-30,2015-06-28,2016-08-11 16:59:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6078000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2,2015-03-30,2015-06-28,2016-08-11 16:59:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3595000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2,2015-03-30,2015-06-28,2016-08-11 16:59:40+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-55000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2,2015-03-30,2015-06-28,2016-08-11 16:59:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-55000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2,2015-03-30,2015-06-28,2016-08-11 16:59:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3539000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2,2015-03-30,2015-06-28,2016-08-11 16:59:40+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,905000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2,2015-03-30,2015-06-28,2016-08-11 16:59:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2635000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2,2015-03-30,2015-06-28,2016-08-11 16:59:40+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,1000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2,2015-03-30,2015-06-28,2016-08-11 16:59:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2635000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2,2015-03-30,2015-06-28,2016-08-11 16:59:40+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,9000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2,2015-03-30,2015-06-28,2016-08-11 16:59:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2626000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2,2015-03-30,2015-06-28,2016-08-11 16:59:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6159000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2,2015-03-30,2015-06-28,2016-08-11 16:59:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.43
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2,2015-03-30,2015-06-28,2016-08-11 16:59:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6243000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2,2015-03-30,2015-06-28,2016-08-11 16:59:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.42
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2,2015-03-30,2015-06-28,2016-08-11 16:59:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6107000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2,2015-03-30,2015-06-28,2016-08-11 16:59:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.43
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2,2015-03-30,2015-06-28,2016-08-11 16:59:40+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.28
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2YTD,2015-01-01,2015-06-28,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,22717000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2YTD,2015-01-01,2015-06-28,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,22717000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2YTD,2015-01-01,2015-06-28,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4018000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2YTD,2015-01-01,2015-06-28,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4018000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2YTD,2015-01-01,2015-06-28,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18699000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2YTD,2015-01-01,2015-06-28,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6490000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2YTD,2015-01-01,2015-06-28,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3619000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2YTD,2015-01-01,2015-06-28,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1812000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2YTD,2015-01-01,2015-06-28,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,146000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2YTD,2015-01-01,2015-06-28,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12067000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2YTD,2015-01-01,2015-06-28,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6632000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2YTD,2015-01-01,2015-06-28,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-9000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2YTD,2015-01-01,2015-06-28,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2YTD,2015-01-01,2015-06-28,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6621000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2YTD,2015-01-01,2015-06-28,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1611000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2YTD,2015-01-01,2015-06-28,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5011000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2YTD,2015-01-01,2015-06-28,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,6000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2YTD,2015-01-01,2015-06-28,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5016000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2YTD,2015-01-01,2015-06-28,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,15000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2YTD,2015-01-01,2015-06-28,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5002000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2YTD,2015-01-01,2015-06-28,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6159000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2YTD,2015-01-01,2015-06-28,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.81
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2YTD,2015-01-01,2015-06-28,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6243000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2YTD,2015-01-01,2015-06-28,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.8
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2YTD,2015-01-01,2015-06-28,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6107000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2YTD,2015-01-01,2015-06-28,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.81
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2YTD,2015-01-01,2015-06-28,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.56
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2TTM,2014-06-30,2015-06-28,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,48196000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2TTM,2014-06-30,2015-06-28,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,48196000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2TTM,2014-06-30,2015-06-28,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9088000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2TTM,2014-06-30,2015-06-28,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9088000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2TTM,2014-06-30,2015-06-28,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,39108000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2TTM,2014-06-30,2015-06-28,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14027000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2TTM,2014-06-30,2015-06-28,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8630000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2TTM,2014-06-30,2015-06-28,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3733000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2TTM,2014-06-30,2015-06-28,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,257000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2TTM,2014-06-30,2015-06-28,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26647000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2TTM,2014-06-30,2015-06-28,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,12461000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2TTM,2014-06-30,2015-06-28,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-448000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2TTM,2014-06-30,2015-06-28,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-448000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2TTM,2014-06-30,2015-06-28,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,12011000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2TTM,2014-06-30,2015-06-28,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3067000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2TTM,2014-06-30,2015-06-28,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8944000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2TTM,2014-06-30,2015-06-28,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-67000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2TTM,2014-06-30,2015-06-28,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,49000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2TTM,2014-06-30,2015-06-28,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8925000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2TTM,2014-06-30,2015-06-28,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,29000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2TTM,2014-06-30,2015-06-28,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8896000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2TTM,2014-06-30,2015-06-28,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6159000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2TTM,2014-06-30,2015-06-28,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.43
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2TTM,2014-06-30,2015-06-28,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6243000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2TTM,2014-06-30,2015-06-28,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.41
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2TTM,2014-06-30,2015-06-28,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6107000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2TTM,2014-06-30,2015-06-28,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.43
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q2TTM,2014-06-30,2015-06-28,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.08
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1,2015-01-01,2015-03-29,2016-05-12 16:53:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10864000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1,2015-01-01,2015-03-29,2016-05-12 16:53:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10864000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1,2015-01-01,2015-03-29,2016-05-12 16:53:45+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1838000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1,2015-01-01,2015-03-29,2016-05-12 16:53:45+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1838000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1,2015-01-01,2015-03-29,2016-05-12 16:53:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9026000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1,2015-01-01,2015-03-29,2016-05-12 16:53:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3104000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1,2015-01-01,2015-03-29,2016-05-12 16:53:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1885000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1,2015-01-01,2015-03-29,2016-05-12 16:53:45+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,940000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1,2015-01-01,2015-03-29,2016-05-12 16:53:45+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,60000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1,2015-01-01,2015-03-29,2016-05-12 16:53:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5989000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1,2015-01-01,2015-03-29,2016-05-12 16:53:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3037000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1,2015-01-01,2015-03-29,2016-05-12 16:53:45+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,46000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1,2015-01-01,2015-03-29,2016-05-12 16:53:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,46000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1,2015-01-01,2015-03-29,2016-05-12 16:53:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3082000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1,2015-01-01,2015-03-29,2016-05-12 16:53:45+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,706000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1,2015-01-01,2015-03-29,2016-05-12 16:53:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2376000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1,2015-01-01,2015-03-29,2016-05-12 16:53:45+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,5000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1,2015-01-01,2015-03-29,2016-05-12 16:53:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2381000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1,2015-01-01,2015-03-29,2016-05-12 16:53:45+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,6000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1,2015-01-01,2015-03-29,2016-05-12 16:53:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2376000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1,2015-01-01,2015-03-29,2016-05-12 16:53:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6203000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1,2015-01-01,2015-03-29,2016-05-12 16:53:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.38
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1,2015-01-01,2015-03-29,2016-05-12 16:53:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6292000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1,2015-01-01,2015-03-29,2016-05-12 16:53:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.38
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1,2015-01-01,2015-03-29,2016-05-12 16:53:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6252600000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1,2015-01-01,2015-03-29,2016-05-12 16:53:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.38
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1,2015-01-01,2015-03-29,2016-05-12 16:53:45+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.28
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1TTM,2014-03-31,2015-03-29,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,49116000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1TTM,2014-03-31,2015-03-29,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,49116000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1TTM,2014-03-31,2015-03-29,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9370000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1TTM,2014-03-31,2015-03-29,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9370000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1TTM,2014-03-31,2015-03-29,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,39746000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1TTM,2014-03-31,2015-03-29,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14161000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1TTM,2014-03-31,2015-03-29,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8655000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1TTM,2014-03-31,2015-03-29,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3862000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1TTM,2014-03-31,2015-03-29,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,252000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1TTM,2014-03-31,2015-03-29,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26930000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1TTM,2014-03-31,2015-03-29,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,12816000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1TTM,2014-03-31,2015-03-29,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-340000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1TTM,2014-03-31,2015-03-29,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-340000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1TTM,2014-03-31,2015-03-29,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,12475000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1TTM,2014-03-31,2015-03-29,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3244000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1TTM,2014-03-31,2015-03-29,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9230000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1TTM,2014-03-31,2015-03-29,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-68000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1TTM,2014-03-31,2015-03-29,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,49000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1TTM,2014-03-31,2015-03-29,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,9211000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1TTM,2014-03-31,2015-03-29,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,29000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1TTM,2014-03-31,2015-03-29,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,9182000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1TTM,2014-03-31,2015-03-29,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6203000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1TTM,2014-03-31,2015-03-29,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.46
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1TTM,2014-03-31,2015-03-29,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6292000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1TTM,2014-03-31,2015-03-29,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.44
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1TTM,2014-03-31,2015-03-29,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6252600000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1TTM,2014-03-31,2015-03-29,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.46
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2015.0,Q1TTM,2014-03-31,2015-03-29,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.06
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,FY,2016-01-01,2016-12-31,2019-02-28 14:35:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,52824000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,FY,2016-01-01,2016-12-31,2019-02-28 14:35:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,52824000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,FY,2016-01-01,2016-12-31,2019-02-28 14:35:32+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,12322000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,FY,2016-01-01,2016-12-31,2019-02-28 14:35:32+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,12322000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,FY,2016-01-01,2016-12-31,2019-02-28 14:35:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,40502000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,FY,2016-01-01,2016-12-31,2019-02-28 14:35:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14844000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,FY,2016-01-01,2016-12-31,2019-02-28 14:35:32+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7892000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,FY,2016-01-01,2016-12-31,2019-02-28 14:35:32+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4056000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,FY,2016-01-01,2016-12-31,2019-02-28 14:35:32+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1565000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,FY,2016-01-01,2016-12-31,2019-02-28 14:35:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,28357000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,FY,2016-01-01,2016-12-31,2019-02-28 14:35:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,12145000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,FY,2016-01-01,2016-12-31,2019-02-28 14:35:32+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3794000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,FY,2016-01-01,2016-12-31,2019-02-28 14:35:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3794000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,FY,2016-01-01,2016-12-31,2019-02-28 14:35:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8351000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,FY,2016-01-01,2016-12-31,2019-02-28 14:35:32+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1123000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,FY,2016-01-01,2016-12-31,2019-02-28 14:35:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7229000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,FY,2016-01-01,2016-12-31,2019-02-28 14:35:32+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,17000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,FY,2016-01-01,2016-12-31,2019-02-28 14:35:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7246000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,FY,2016-01-01,2016-12-31,2019-02-28 14:35:32+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,31000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,FY,2016-01-01,2016-12-31,2019-02-28 14:35:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7215000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,FY,2016-01-01,2016-12-31,2019-02-28 14:35:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6089000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,FY,2016-01-01,2016-12-31,2019-02-28 14:35:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.18
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,FY,2016-01-01,2016-12-31,2019-02-28 14:35:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6159000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,FY,2016-01-01,2016-12-31,2019-02-28 14:35:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.17
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,FY,2016-01-01,2016-12-31,2019-02-28 14:35:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6114400000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,FY,2016-01-01,2016-12-31,2019-02-28 14:35:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.18
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,FY,2016-01-01,2016-12-31,2019-02-28 14:35:32+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.22
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q4,2016-10-03,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13627000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q4,2016-10-03,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13627000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q4,2016-10-03,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3212000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q4,2016-10-03,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3212000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q4,2016-10-03,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10415000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q4,2016-10-03,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4429000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q4,2016-10-03,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2532000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q4,2016-10-03,2016-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1121000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q4,2016-10-03,2016-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,577000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q4,2016-10-03,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8659000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q4,2016-10-03,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1756000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q4,2016-10-03,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-979000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q4,2016-10-03,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-979000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q4,2016-10-03,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,776000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q4,2016-10-03,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,14000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q4,2016-10-03,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,764000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q4,2016-10-03,2016-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,16000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q4,2016-10-03,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,780000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q4,2016-10-03,2016-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,6000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q4,2016-10-03,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,775000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q4,2016-10-03,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6089000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q4,2016-10-03,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.13
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q4,2016-10-03,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6159000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q4,2016-10-03,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.13
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q4,2016-10-03,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6114400000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q4,2016-10-03,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.13
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q4,2016-10-03,2016-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.9
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3,2016-07-04,2016-10-02,2017-11-09 16:04:36+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13045000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3,2016-07-04,2016-10-02,2017-11-09 16:04:36+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13045000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3,2016-07-04,2016-10-02,2017-11-09 16:04:36+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3085000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3,2016-07-04,2016-10-02,2017-11-09 16:04:36+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3085000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3,2016-07-04,2016-10-02,2017-11-09 16:04:36+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9960000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3,2016-07-04,2016-10-02,2017-11-09 16:04:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3559000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3,2016-07-04,2016-10-02,2017-11-09 16:04:36+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1881000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3,2016-07-04,2016-10-02,2017-11-09 16:04:36+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,968000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3,2016-07-04,2016-10-02,2017-11-09 16:04:36+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,531000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3,2016-07-04,2016-10-02,2017-11-09 16:04:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6939000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3,2016-07-04,2016-10-02,2017-11-09 16:04:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3021000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3,2016-07-04,2016-10-02,2017-11-09 16:04:36+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1417000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3,2016-07-04,2016-10-02,2017-11-09 16:04:36+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1417000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3,2016-07-04,2016-10-02,2017-11-09 16:04:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1604000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3,2016-07-04,2016-10-02,2017-11-09 16:04:36+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,249000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3,2016-07-04,2016-10-02,2017-11-09 16:04:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1355000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3,2016-07-04,2016-10-02,2017-11-09 16:04:36+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3,2016-07-04,2016-10-02,2017-11-09 16:04:36+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1355000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3,2016-07-04,2016-10-02,2017-11-09 16:04:36+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3,2016-07-04,2016-10-02,2017-11-09 16:04:36+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1355000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3,2016-07-04,2016-10-02,2017-11-09 16:04:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6066000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3,2016-07-04,2016-10-02,2017-11-09 16:04:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.22
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3,2016-07-04,2016-10-02,2017-11-09 16:04:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6150000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3,2016-07-04,2016-10-02,2017-11-09 16:04:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.22
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3,2016-07-04,2016-10-02,2017-11-09 16:04:36+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6159100000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3,2016-07-04,2016-10-02,2017-11-09 16:04:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.22
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3,2016-07-04,2016-10-02,2017-11-09 16:04:36+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.3
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3YTD,2016-01-01,2016-10-02,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,39197000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3YTD,2016-01-01,2016-10-02,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,39197000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3YTD,2016-01-01,2016-10-02,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9110000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3YTD,2016-01-01,2016-10-02,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9110000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3YTD,2016-01-01,2016-10-02,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,30087000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3YTD,2016-01-01,2016-10-02,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10415000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3YTD,2016-01-01,2016-10-02,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5360000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3YTD,2016-01-01,2016-10-02,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,2935000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3YTD,2016-01-01,2016-10-02,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,988000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3YTD,2016-01-01,2016-10-02,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19698000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3YTD,2016-01-01,2016-10-02,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10389000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3YTD,2016-01-01,2016-10-02,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2815000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3YTD,2016-01-01,2016-10-02,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2815000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3YTD,2016-01-01,2016-10-02,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,7575000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3YTD,2016-01-01,2016-10-02,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1109000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3YTD,2016-01-01,2016-10-02,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6465000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3YTD,2016-01-01,2016-10-02,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,1000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3YTD,2016-01-01,2016-10-02,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6466000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3YTD,2016-01-01,2016-10-02,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,25000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3YTD,2016-01-01,2016-10-02,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6440000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3YTD,2016-01-01,2016-10-02,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6066000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3YTD,2016-01-01,2016-10-02,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.05
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3YTD,2016-01-01,2016-10-02,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6150000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3YTD,2016-01-01,2016-10-02,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.04
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3YTD,2016-01-01,2016-10-02,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6159100000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3YTD,2016-01-01,2016-10-02,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.05
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3YTD,2016-01-01,2016-10-02,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.9
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3TTM,2015-09-28,2016-10-02,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,53244000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3TTM,2015-09-28,2016-10-02,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,53244000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3TTM,2015-09-28,2016-10-02,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,12521000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3TTM,2015-09-28,2016-10-02,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,12521000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3TTM,2015-09-28,2016-10-02,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,40723000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3TTM,2015-09-28,2016-10-02,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15464000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3TTM,2015-09-28,2016-10-02,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7709000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3TTM,2015-09-28,2016-10-02,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3914000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3TTM,2015-09-28,2016-10-02,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1413000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3TTM,2015-09-28,2016-10-02,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,28500000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3TTM,2015-09-28,2016-10-02,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,12223000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3TTM,2015-09-28,2016-10-02,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5005000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3TTM,2015-09-28,2016-10-02,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5005000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3TTM,2015-09-28,2016-10-02,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,7222000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3TTM,2015-09-28,2016-10-02,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,921000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3TTM,2015-09-28,2016-10-02,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6299000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3TTM,2015-09-28,2016-10-02,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-13000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3TTM,2015-09-28,2016-10-02,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6297000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3TTM,2015-09-28,2016-10-02,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,27000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3TTM,2015-09-28,2016-10-02,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6268000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3TTM,2015-09-28,2016-10-02,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6066000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3TTM,2015-09-28,2016-10-02,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.02
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3TTM,2015-09-28,2016-10-02,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6150000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3TTM,2015-09-28,2016-10-02,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.01
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3TTM,2015-09-28,2016-10-02,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6159100000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3TTM,2015-09-28,2016-10-02,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.02
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q3TTM,2015-09-28,2016-10-02,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.18
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2,2016-04-04,2016-07-03,2017-08-10 16:09:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13147000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2,2016-04-04,2016-07-03,2017-08-10 16:09:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13147000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2,2016-04-04,2016-07-03,2017-08-10 16:09:11+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3174000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2,2016-04-04,2016-07-03,2017-08-10 16:09:11+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3174000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2,2016-04-04,2016-07-03,2017-08-10 16:09:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9973000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2,2016-04-04,2016-07-03,2017-08-10 16:09:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3471000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2,2016-04-04,2016-07-03,2017-08-10 16:09:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1748000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2,2016-04-04,2016-07-03,2017-08-10 16:09:11+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,961000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2,2016-04-04,2016-07-03,2017-08-10 16:09:11+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,316000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2,2016-04-04,2016-07-03,2017-08-10 16:09:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6496000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2,2016-04-04,2016-07-03,2017-08-10 16:09:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3477000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2,2016-04-04,2016-07-03,2017-08-10 16:09:11+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1068000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2,2016-04-04,2016-07-03,2017-08-10 16:09:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1068000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2,2016-04-04,2016-07-03,2017-08-10 16:09:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2410000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2,2016-04-04,2016-07-03,2017-08-10 16:09:11+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,347000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2,2016-04-04,2016-07-03,2017-08-10 16:09:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2062000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2,2016-04-04,2016-07-03,2017-08-10 16:09:11+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,1000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2,2016-04-04,2016-07-03,2017-08-10 16:09:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2063000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2,2016-04-04,2016-07-03,2017-08-10 16:09:11+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,16000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2,2016-04-04,2016-07-03,2017-08-10 16:09:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2047000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2,2016-04-04,2016-07-03,2017-08-10 16:09:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6068000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2,2016-04-04,2016-07-03,2017-08-10 16:09:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.34
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2,2016-04-04,2016-07-03,2017-08-10 16:09:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6149000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2,2016-04-04,2016-07-03,2017-08-10 16:09:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.33
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2,2016-04-04,2016-07-03,2017-08-10 16:09:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6020600000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2,2016-04-04,2016-07-03,2017-08-10 16:09:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.34
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2,2016-04-04,2016-07-03,2017-08-10 16:09:11+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.3
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2YTD,2016-01-01,2016-07-03,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,26152000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2YTD,2016-01-01,2016-07-03,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,26152000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2YTD,2016-01-01,2016-07-03,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6025000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2YTD,2016-01-01,2016-07-03,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6025000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2YTD,2016-01-01,2016-07-03,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,20127000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2YTD,2016-01-01,2016-07-03,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6856000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2YTD,2016-01-01,2016-07-03,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3479000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2YTD,2016-01-01,2016-07-03,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1967000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2YTD,2016-01-01,2016-07-03,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,457000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2YTD,2016-01-01,2016-07-03,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12759000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2YTD,2016-01-01,2016-07-03,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7368000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2YTD,2016-01-01,2016-07-03,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1398000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2YTD,2016-01-01,2016-07-03,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1398000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2YTD,2016-01-01,2016-07-03,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5971000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2YTD,2016-01-01,2016-07-03,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,860000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2YTD,2016-01-01,2016-07-03,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5110000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2YTD,2016-01-01,2016-07-03,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,1000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2YTD,2016-01-01,2016-07-03,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5111000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2YTD,2016-01-01,2016-07-03,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,25000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2YTD,2016-01-01,2016-07-03,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5085000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2YTD,2016-01-01,2016-07-03,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6068000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2YTD,2016-01-01,2016-07-03,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.83
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2YTD,2016-01-01,2016-07-03,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6149000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2YTD,2016-01-01,2016-07-03,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.82
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2YTD,2016-01-01,2016-07-03,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6020600000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2YTD,2016-01-01,2016-07-03,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.83
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2YTD,2016-01-01,2016-07-03,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.6
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2TTM,2015-06-29,2016-07-03,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,52286000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2TTM,2015-06-29,2016-07-03,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,52286000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2TTM,2015-06-29,2016-07-03,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,11655000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2TTM,2015-06-29,2016-07-03,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,11655000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2TTM,2015-06-29,2016-07-03,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,40631000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2TTM,2015-06-29,2016-07-03,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15175000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2TTM,2015-06-29,2016-07-03,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7550000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2TTM,2015-06-29,2016-07-03,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3883000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2TTM,2015-06-29,2016-07-03,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1463000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2TTM,2015-06-29,2016-07-03,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,28071000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2TTM,2015-06-29,2016-07-03,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,12560000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2TTM,2015-06-29,2016-07-03,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4249000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2TTM,2015-06-29,2016-07-03,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4249000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2TTM,2015-06-29,2016-07-03,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8315000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2TTM,2015-06-29,2016-07-03,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1239000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2TTM,2015-06-29,2016-07-03,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7074000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2TTM,2015-06-29,2016-07-03,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-5000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2TTM,2015-06-29,2016-07-03,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7081000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2TTM,2015-06-29,2016-07-03,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,36000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2TTM,2015-06-29,2016-07-03,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7043000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2TTM,2015-06-29,2016-07-03,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6068000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2TTM,2015-06-29,2016-07-03,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.15
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2TTM,2015-06-29,2016-07-03,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6149000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2TTM,2015-06-29,2016-07-03,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.13
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2TTM,2015-06-29,2016-07-03,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6020600000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2TTM,2015-06-29,2016-07-03,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.15
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q2TTM,2015-06-29,2016-07-03,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.16
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1,2016-01-01,2016-04-03,2017-05-11 16:20:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13005000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1,2016-01-01,2016-04-03,2017-05-11 16:20:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13005000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1,2016-01-01,2016-04-03,2017-05-11 16:20:31+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2851000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1,2016-01-01,2016-04-03,2017-05-11 16:20:31+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2851000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1,2016-01-01,2016-04-03,2017-05-11 16:20:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10154000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1,2016-01-01,2016-04-03,2017-05-11 16:20:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3385000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1,2016-01-01,2016-04-03,2017-05-11 16:20:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1731000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1,2016-01-01,2016-04-03,2017-05-11 16:20:31+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1006000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1,2016-01-01,2016-04-03,2017-05-11 16:20:31+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,141000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1,2016-01-01,2016-04-03,2017-05-11 16:20:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6263000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1,2016-01-01,2016-04-03,2017-05-11 16:20:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3891000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1,2016-01-01,2016-04-03,2017-05-11 16:20:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-330000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1,2016-01-01,2016-04-03,2017-05-11 16:20:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-330000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1,2016-01-01,2016-04-03,2017-05-11 16:20:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3561000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1,2016-01-01,2016-04-03,2017-05-11 16:20:31+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,513000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1,2016-01-01,2016-04-03,2017-05-11 16:20:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3048000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1,2016-01-01,2016-04-03,2017-05-11 16:20:31+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1,2016-01-01,2016-04-03,2017-05-11 16:20:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3048000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1,2016-01-01,2016-04-03,2017-05-11 16:20:31+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,9000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1,2016-01-01,2016-04-03,2017-05-11 16:20:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3038000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1,2016-01-01,2016-04-03,2017-05-11 16:20:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6150000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1,2016-01-01,2016-04-03,2017-05-11 16:20:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.49
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1,2016-01-01,2016-04-03,2017-05-11 16:20:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6225000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1,2016-01-01,2016-04-03,2017-05-11 16:20:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.49
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1,2016-01-01,2016-04-03,2017-05-11 16:20:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6200000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1,2016-01-01,2016-04-03,2017-05-11 16:20:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.49
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1,2016-01-01,2016-04-03,2017-05-11 16:20:31+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.3
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1TTM,2015-03-30,2016-04-03,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,50992000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1TTM,2015-03-30,2016-04-03,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,50992000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1TTM,2015-03-30,2016-04-03,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,10661000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1TTM,2015-03-30,2016-04-03,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,10661000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1TTM,2015-03-30,2016-04-03,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,40331000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1TTM,2015-03-30,2016-04-03,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15090000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1TTM,2015-03-30,2016-04-03,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7536000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1TTM,2015-03-30,2016-04-03,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3794000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1TTM,2015-03-30,2016-04-03,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1233000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1TTM,2015-03-30,2016-04-03,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27653000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1TTM,2015-03-30,2016-04-03,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,12678000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1TTM,2015-03-30,2016-04-03,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3236000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1TTM,2015-03-30,2016-04-03,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3236000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1TTM,2015-03-30,2016-04-03,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9444000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1TTM,2015-03-30,2016-04-03,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1797000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1TTM,2015-03-30,2016-04-03,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7647000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1TTM,2015-03-30,2016-04-03,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-5000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1TTM,2015-03-30,2016-04-03,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7653000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1TTM,2015-03-30,2016-04-03,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,29000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1TTM,2015-03-30,2016-04-03,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7622000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1TTM,2015-03-30,2016-04-03,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6150000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1TTM,2015-03-30,2016-04-03,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.24
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1TTM,2015-03-30,2016-04-03,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6225000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1TTM,2015-03-30,2016-04-03,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.22
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1TTM,2015-03-30,2016-04-03,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6200000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1TTM,2015-03-30,2016-04-03,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.24
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2016.0,Q1TTM,2015-03-30,2016-04-03,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.14
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 14:15:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,52544000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 14:15:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,52544000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 14:15:12+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,11228000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 14:15:12+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,11228000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 14:15:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,41316000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 14:15:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14804000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 14:15:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7683000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 14:15:12+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4758000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 14:15:12+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 14:15:12+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,351000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 14:15:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27596000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 14:15:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,13720000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 14:15:12+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1416000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 14:15:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1416000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 14:15:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,12305000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 14:15:12+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-9049000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 14:15:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,21353000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 14:15:12+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,2000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 14:15:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,21355000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 14:15:12+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,47000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 14:15:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,21308000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 14:15:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,5970000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 14:15:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.57
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 14:15:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6058000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 14:15:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.52
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 14:15:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,5968600000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 14:15:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.57
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 14:15:12+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.3
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q4,2017-10-02,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13701000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q4,2017-10-02,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13701000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q4,2017-10-02,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3256000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q4,2017-10-02,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3256000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q4,2017-10-02,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10445000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q4,2017-10-02,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4555000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q4,2017-10-02,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2315000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q4,2017-10-02,2017-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1187000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q4,2017-10-02,2017-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,83000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q4,2017-10-02,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8140000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q4,2017-10-02,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2305000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q4,2017-10-02,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1352000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q4,2017-10-02,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1352000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q4,2017-10-02,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,954000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q4,2017-10-02,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-11336000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q4,2017-10-02,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12288000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q4,2017-10-02,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,12289000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q4,2017-10-02,2017-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,15000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q4,2017-10-02,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,12274000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q4,2017-10-02,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,5970000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q4,2017-10-02,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.05
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q4,2017-10-02,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6058000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q4,2017-10-02,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.03
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q4,2017-10-02,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,5968600000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q4,2017-10-02,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.05
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q4,2017-10-02,2017-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.96
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3,2017-07-03,2017-10-01,2018-11-08 16:42:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13168000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3,2017-07-03,2017-10-01,2018-11-08 16:42:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13168000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3,2017-07-03,2017-10-01,2018-11-08 16:42:41+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2844000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3,2017-07-03,2017-10-01,2018-11-08 16:42:41+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2844000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3,2017-07-03,2017-10-01,2018-11-08 16:42:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10324000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3,2017-07-03,2017-10-01,2018-11-08 16:42:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3504000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3,2017-07-03,2017-10-01,2018-11-08 16:42:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1865000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3,2017-07-03,2017-10-01,2018-11-08 16:42:41+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1177000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3,2017-07-03,2017-10-01,2018-11-08 16:42:41+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,114000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3,2017-07-03,2017-10-01,2018-11-08 16:42:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6660000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3,2017-07-03,2017-10-01,2018-11-08 16:42:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3664000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3,2017-07-03,2017-10-01,2018-11-08 16:42:41+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-79000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3,2017-07-03,2017-10-01,2018-11-08 16:42:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-79000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3,2017-07-03,2017-10-01,2018-11-08 16:42:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3585000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3,2017-07-03,2017-10-01,2018-11-08 16:42:41+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,727000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3,2017-07-03,2017-10-01,2018-11-08 16:42:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2858000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3,2017-07-03,2017-10-01,2018-11-08 16:42:41+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3,2017-07-03,2017-10-01,2018-11-08 16:42:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2858000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3,2017-07-03,2017-10-01,2018-11-08 16:42:41+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,18000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3,2017-07-03,2017-10-01,2018-11-08 16:42:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2840000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3,2017-07-03,2017-10-01,2018-11-08 16:42:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,5951000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3,2017-07-03,2017-10-01,2018-11-08 16:42:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.48
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3,2017-07-03,2017-10-01,2018-11-08 16:42:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6041000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3,2017-07-03,2017-10-01,2018-11-08 16:42:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.47
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3,2017-07-03,2017-10-01,2018-11-08 16:42:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,5916700000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3,2017-07-03,2017-10-01,2018-11-08 16:42:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.48
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3,2017-07-03,2017-10-01,2018-11-08 16:42:41+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.32
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3YTD,2017-01-01,2017-10-01,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,38843000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3YTD,2017-01-01,2017-10-01,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,38843000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3YTD,2017-01-01,2017-10-01,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7972000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3YTD,2017-01-01,2017-10-01,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7972000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3YTD,2017-01-01,2017-10-01,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,30871000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3YTD,2017-01-01,2017-10-01,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10249000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3YTD,2017-01-01,2017-10-01,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5368000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3YTD,2017-01-01,2017-10-01,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3571000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3YTD,2017-01-01,2017-10-01,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,268000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3YTD,2017-01-01,2017-10-01,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19456000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3YTD,2017-01-01,2017-10-01,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,11415000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3YTD,2017-01-01,2017-10-01,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-64000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3YTD,2017-01-01,2017-10-01,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-64000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3YTD,2017-01-01,2017-10-01,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,11351000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3YTD,2017-01-01,2017-10-01,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2287000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3YTD,2017-01-01,2017-10-01,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9065000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3YTD,2017-01-01,2017-10-01,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,2000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3YTD,2017-01-01,2017-10-01,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,9066000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3YTD,2017-01-01,2017-10-01,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,32000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3YTD,2017-01-01,2017-10-01,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,9034000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3YTD,2017-01-01,2017-10-01,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,5951000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3YTD,2017-01-01,2017-10-01,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.52
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3YTD,2017-01-01,2017-10-01,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6041000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3YTD,2017-01-01,2017-10-01,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.49
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3YTD,2017-01-01,2017-10-01,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,5916700000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3YTD,2017-01-01,2017-10-01,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.52
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3YTD,2017-01-01,2017-10-01,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.96
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3TTM,2016-10-03,2017-10-01,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,52470000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3TTM,2016-10-03,2017-10-01,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,52470000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3TTM,2016-10-03,2017-10-01,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,11184000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3TTM,2016-10-03,2017-10-01,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,11184000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3TTM,2016-10-03,2017-10-01,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,41286000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3TTM,2016-10-03,2017-10-01,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14678000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3TTM,2016-10-03,2017-10-01,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7900000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3TTM,2016-10-03,2017-10-01,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4692000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3TTM,2016-10-03,2017-10-01,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,845000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3TTM,2016-10-03,2017-10-01,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,28115000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3TTM,2016-10-03,2017-10-01,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,13171000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3TTM,2016-10-03,2017-10-01,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1043000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3TTM,2016-10-03,2017-10-01,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1043000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3TTM,2016-10-03,2017-10-01,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,12127000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3TTM,2016-10-03,2017-10-01,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2301000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3TTM,2016-10-03,2017-10-01,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9829000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3TTM,2016-10-03,2017-10-01,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,18000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3TTM,2016-10-03,2017-10-01,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,9846000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3TTM,2016-10-03,2017-10-01,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,38000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3TTM,2016-10-03,2017-10-01,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,9809000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3TTM,2016-10-03,2017-10-01,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,5951000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3TTM,2016-10-03,2017-10-01,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.65
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3TTM,2016-10-03,2017-10-01,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6041000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3TTM,2016-10-03,2017-10-01,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.62
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3TTM,2016-10-03,2017-10-01,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,5916700000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3TTM,2016-10-03,2017-10-01,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.65
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q3TTM,2016-10-03,2017-10-01,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.06
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2,2017-04-03,2017-07-02,2018-08-09 16:29:29+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12896000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2,2017-04-03,2017-07-02,2018-08-09 16:29:29+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12896000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2,2017-04-03,2017-07-02,2018-08-09 16:29:29+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2660000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2,2017-04-03,2017-07-02,2018-08-09 16:29:29+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2660000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2,2017-04-03,2017-07-02,2018-08-09 16:29:29+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10236000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2,2017-04-03,2017-07-02,2018-08-09 16:29:29+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3430000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2,2017-04-03,2017-07-02,2018-08-09 16:29:29+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1787000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2,2017-04-03,2017-07-02,2018-08-09 16:29:29+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1208000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2,2017-04-03,2017-07-02,2018-08-09 16:29:29+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,70000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2,2017-04-03,2017-07-02,2018-08-09 16:29:29+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6495000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2,2017-04-03,2017-07-02,2018-08-09 16:29:29+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3741000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2,2017-04-03,2017-07-02,2018-08-09 16:29:29+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,75000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2,2017-04-03,2017-07-02,2018-08-09 16:29:29+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,75000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2,2017-04-03,2017-07-02,2018-08-09 16:29:29+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3815000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2,2017-04-03,2017-07-02,2018-08-09 16:29:29+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,739000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2,2017-04-03,2017-07-02,2018-08-09 16:29:29+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3077000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2,2017-04-03,2017-07-02,2018-08-09 16:29:29+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,2000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2,2017-04-03,2017-07-02,2018-08-09 16:29:29+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3078000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2,2017-04-03,2017-07-02,2018-08-09 16:29:29+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,5000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2,2017-04-03,2017-07-02,2018-08-09 16:29:29+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3073000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2,2017-04-03,2017-07-02,2018-08-09 16:29:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,5958000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2,2017-04-03,2017-07-02,2018-08-09 16:29:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.52
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2,2017-04-03,2017-07-02,2018-08-09 16:29:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6037000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2,2017-04-03,2017-07-02,2018-08-09 16:29:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.51
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2,2017-04-03,2017-07-02,2018-08-09 16:29:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,5909600000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2,2017-04-03,2017-07-02,2018-08-09 16:29:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.52
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2,2017-04-03,2017-07-02,2018-08-09 16:29:29+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.32
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2YTD,2017-01-01,2017-07-02,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,25675000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2YTD,2017-01-01,2017-07-02,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,25675000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2YTD,2017-01-01,2017-07-02,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5128000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2YTD,2017-01-01,2017-07-02,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5128000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2YTD,2017-01-01,2017-07-02,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,20547000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2YTD,2017-01-01,2017-07-02,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6745000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2YTD,2017-01-01,2017-07-02,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3503000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2YTD,2017-01-01,2017-07-02,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,2394000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2YTD,2017-01-01,2017-07-02,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,154000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2YTD,2017-01-01,2017-07-02,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12796000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2YTD,2017-01-01,2017-07-02,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7751000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2YTD,2017-01-01,2017-07-02,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,15000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2YTD,2017-01-01,2017-07-02,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,15000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2YTD,2017-01-01,2017-07-02,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,7766000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2YTD,2017-01-01,2017-07-02,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1560000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2YTD,2017-01-01,2017-07-02,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6207000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2YTD,2017-01-01,2017-07-02,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,2000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2YTD,2017-01-01,2017-07-02,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6208000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2YTD,2017-01-01,2017-07-02,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,14000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2YTD,2017-01-01,2017-07-02,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6194000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2YTD,2017-01-01,2017-07-02,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,5958000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2YTD,2017-01-01,2017-07-02,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.04
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2YTD,2017-01-01,2017-07-02,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6037000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2YTD,2017-01-01,2017-07-02,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.02
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2YTD,2017-01-01,2017-07-02,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,5909600000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2YTD,2017-01-01,2017-07-02,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.04
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2YTD,2017-01-01,2017-07-02,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.64
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2TTM,2016-07-04,2017-07-02,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,52347000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2TTM,2016-07-04,2017-07-02,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,52347000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2TTM,2016-07-04,2017-07-02,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,11425000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2TTM,2016-07-04,2017-07-02,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,11425000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2TTM,2016-07-04,2017-07-02,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,40922000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2TTM,2016-07-04,2017-07-02,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14733000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2TTM,2016-07-04,2017-07-02,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7916000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2TTM,2016-07-04,2017-07-02,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4483000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2TTM,2016-07-04,2017-07-02,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1262000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2TTM,2016-07-04,2017-07-02,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,28394000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2TTM,2016-07-04,2017-07-02,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,12528000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2TTM,2016-07-04,2017-07-02,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2381000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2TTM,2016-07-04,2017-07-02,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2381000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2TTM,2016-07-04,2017-07-02,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,10146000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2TTM,2016-07-04,2017-07-02,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1823000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2TTM,2016-07-04,2017-07-02,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8326000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2TTM,2016-07-04,2017-07-02,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,18000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2TTM,2016-07-04,2017-07-02,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8343000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2TTM,2016-07-04,2017-07-02,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,20000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2TTM,2016-07-04,2017-07-02,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8324000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2TTM,2016-07-04,2017-07-02,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,5958000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2TTM,2016-07-04,2017-07-02,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.39
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2TTM,2016-07-04,2017-07-02,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6037000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2TTM,2016-07-04,2017-07-02,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.37
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2TTM,2016-07-04,2017-07-02,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,5909600000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2TTM,2016-07-04,2017-07-02,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.39
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q2TTM,2016-07-04,2017-07-02,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.04
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1,2017-01-01,2017-04-02,2018-05-10 13:32:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12779000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1,2017-01-01,2017-04-02,2018-05-10 13:32:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12779000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1,2017-01-01,2017-04-02,2018-05-10 13:32:01+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2468000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1,2017-01-01,2017-04-02,2018-05-10 13:32:01+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2468000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1,2017-01-01,2017-04-02,2018-05-10 13:32:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10311000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1,2017-01-01,2017-04-02,2018-05-10 13:32:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3315000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1,2017-01-01,2017-04-02,2018-05-10 13:32:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1716000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1,2017-01-01,2017-04-02,2018-05-10 13:32:01+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1186000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1,2017-01-01,2017-04-02,2018-05-10 13:32:01+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,84000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1,2017-01-01,2017-04-02,2018-05-10 13:32:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6301000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1,2017-01-01,2017-04-02,2018-05-10 13:32:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4010000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1,2017-01-01,2017-04-02,2018-05-10 13:32:01+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-60000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1,2017-01-01,2017-04-02,2018-05-10 13:32:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-60000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1,2017-01-01,2017-04-02,2018-05-10 13:32:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3951000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1,2017-01-01,2017-04-02,2018-05-10 13:32:01+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,821000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1,2017-01-01,2017-04-02,2018-05-10 13:32:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3130000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1,2017-01-01,2017-04-02,2018-05-10 13:32:01+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1,2017-01-01,2017-04-02,2018-05-10 13:32:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3130000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1,2017-01-01,2017-04-02,2018-05-10 13:32:01+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,9000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1,2017-01-01,2017-04-02,2018-05-10 13:32:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3121000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1,2017-01-01,2017-04-02,2018-05-10 13:32:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6006000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1,2017-01-01,2017-04-02,2018-05-10 13:32:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.52
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1,2017-01-01,2017-04-02,2018-05-10 13:32:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6092000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1,2017-01-01,2017-04-02,2018-05-10 13:32:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.51
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1,2017-01-01,2017-04-02,2018-05-10 13:32:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6001900000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1,2017-01-01,2017-04-02,2018-05-10 13:32:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.52
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1,2017-01-01,2017-04-02,2018-05-10 13:32:01+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.32
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1TTM,2016-04-04,2017-04-02,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,52598000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1TTM,2016-04-04,2017-04-02,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,52598000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1TTM,2016-04-04,2017-04-02,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,11939000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1TTM,2016-04-04,2017-04-02,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,11939000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1TTM,2016-04-04,2017-04-02,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,40659000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1TTM,2016-04-04,2017-04-02,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14774000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1TTM,2016-04-04,2017-04-02,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7877000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1TTM,2016-04-04,2017-04-02,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4236000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1TTM,2016-04-04,2017-04-02,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1508000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1TTM,2016-04-04,2017-04-02,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,28395000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1TTM,2016-04-04,2017-04-02,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,12264000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1TTM,2016-04-04,2017-04-02,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3524000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1TTM,2016-04-04,2017-04-02,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3524000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1TTM,2016-04-04,2017-04-02,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8741000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1TTM,2016-04-04,2017-04-02,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1431000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1TTM,2016-04-04,2017-04-02,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7311000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1TTM,2016-04-04,2017-04-02,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,17000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1TTM,2016-04-04,2017-04-02,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7328000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1TTM,2016-04-04,2017-04-02,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,31000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1TTM,2016-04-04,2017-04-02,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7298000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1TTM,2016-04-04,2017-04-02,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6006000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1TTM,2016-04-04,2017-04-02,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.21
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1TTM,2016-04-04,2017-04-02,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6092000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1TTM,2016-04-04,2017-04-02,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.19
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1TTM,2016-04-04,2017-04-02,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6001900000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1TTM,2016-04-04,2017-04-02,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.21
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2017.0,Q1TTM,2016-04-04,2017-04-02,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.02
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 14:15:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,53647000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 14:15:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,53647000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 14:15:12+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,11248000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 14:15:12+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,11248000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 14:15:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,42399000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 14:15:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14455000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 14:15:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8006000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 14:15:12+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4893000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 14:15:12+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 14:15:12+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1044000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 14:15:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,28398000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 14:15:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,14001000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 14:15:12+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2116000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 14:15:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2116000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 14:15:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,11885000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 14:15:12+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,706000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 14:15:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11179000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 14:15:12+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,10000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 14:15:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,11188000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 14:15:12+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,36000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 14:15:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,11153000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 14:15:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,5872000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 14:15:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.9
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 14:15:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,5977000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 14:15:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.87
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 14:15:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,5870000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 14:15:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.9
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 14:15:12+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.38
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13977000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13977000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3075000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3075000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10902000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4007000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2458000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1253000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,872000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8590000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2312000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3259000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3259000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-946000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-564000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-382000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-383000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,12000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-394000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,5872000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,5977000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,5870000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q4,2018-10-01,2018-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.68
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3,2018-07-02,2018-09-30,2019-11-07 15:55:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13298000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3,2018-07-02,2018-09-30,2019-11-07 15:55:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13298000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3,2018-07-02,2018-09-30,2019-11-07 15:55:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2694000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3,2018-07-02,2018-09-30,2019-11-07 15:55:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2694000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3,2018-07-02,2018-09-30,2019-11-07 15:55:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10604000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3,2018-07-02,2018-09-30,2019-11-07 15:55:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3494000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3,2018-07-02,2018-09-30,2019-11-07 15:55:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2008000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3,2018-07-02,2018-09-30,2019-11-07 15:55:42+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1253000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3,2018-07-02,2018-09-30,2019-11-07 15:55:42+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,85000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3,2018-07-02,2018-09-30,2019-11-07 15:55:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6840000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3,2018-07-02,2018-09-30,2019-11-07 15:55:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3764000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3,2018-07-02,2018-09-30,2019-11-07 15:55:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,0.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3,2018-07-02,2018-09-30,2019-11-07 15:55:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,414000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3,2018-07-02,2018-09-30,2019-11-07 15:55:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,414000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3,2018-07-02,2018-09-30,2019-11-07 15:55:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4177000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3,2018-07-02,2018-09-30,2019-11-07 15:55:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,66000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3,2018-07-02,2018-09-30,2019-11-07 15:55:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4111000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3,2018-07-02,2018-09-30,2019-11-07 15:55:42+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,11000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3,2018-07-02,2018-09-30,2019-11-07 15:55:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4122000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3,2018-07-02,2018-09-30,2019-11-07 15:55:42+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,8000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3,2018-07-02,2018-09-30,2019-11-07 15:55:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4114000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3,2018-07-02,2018-09-30,2019-11-07 15:55:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,5875000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3,2018-07-02,2018-09-30,2019-11-07 15:55:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.7
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3,2018-07-02,2018-09-30,2019-11-07 15:55:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,5986000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3,2018-07-02,2018-09-30,2019-11-07 15:55:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.69
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3,2018-07-02,2018-09-30,2019-11-07 15:55:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,5877100000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3,2018-07-02,2018-09-30,2019-11-07 15:55:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.7
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,39670000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,39670000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8173000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8173000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,31497000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10448000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5548000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3640000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,172000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19808000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,11689000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1143000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1143000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,12831000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1270000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11561000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,10000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,11571000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,24000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3YTD,2018-01-01,2018-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,11547000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3YTD,2018-01-01,2018-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,5875000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3YTD,2018-01-01,2018-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.96
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3YTD,2018-01-01,2018-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,5986000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3YTD,2018-01-01,2018-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.93
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3YTD,2018-01-01,2018-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,5877100000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3YTD,2018-01-01,2018-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.96
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3YTD,2018-01-01,2018-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.68
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3TTM,2017-10-02,2018-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,53371000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3TTM,2017-10-02,2018-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,53371000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3TTM,2017-10-02,2018-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,11429000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3TTM,2017-10-02,2018-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,11429000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3TTM,2017-10-02,2018-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,41942000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3TTM,2017-10-02,2018-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15003000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3TTM,2017-10-02,2018-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7863000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3TTM,2017-10-02,2018-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4827000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3TTM,2017-10-02,2018-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,255000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3TTM,2017-10-02,2018-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27948000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3TTM,2017-10-02,2018-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,13994000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3TTM,2017-10-02,2018-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-209000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3TTM,2017-10-02,2018-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-209000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3TTM,2017-10-02,2018-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,13785000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3TTM,2017-10-02,2018-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-10066000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3TTM,2017-10-02,2018-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,23849000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3TTM,2017-10-02,2018-09-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,10000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3TTM,2017-10-02,2018-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,23860000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3TTM,2017-10-02,2018-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,39000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3TTM,2017-10-02,2018-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,23821000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3TTM,2017-10-02,2018-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,5875000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3TTM,2017-10-02,2018-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.01
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3TTM,2017-10-02,2018-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,5986000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3TTM,2017-10-02,2018-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.96
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3TTM,2017-10-02,2018-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,5877100000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3TTM,2017-10-02,2018-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.01
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q3TTM,2017-10-02,2018-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.28
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2,2018-04-02,2018-07-01,2019-08-08 16:23:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13466000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2,2018-04-02,2018-07-01,2019-08-08 16:23:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13466000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2,2018-04-02,2018-07-01,2019-08-08 16:23:48+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2916000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2,2018-04-02,2018-07-01,2019-08-08 16:23:48+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2916000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2,2018-04-02,2018-07-01,2019-08-08 16:23:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10550000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2,2018-04-02,2018-07-01,2019-08-08 16:23:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3542000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2,2018-04-02,2018-07-01,2019-08-08 16:23:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1797000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2,2018-04-02,2018-07-01,2019-08-08 16:23:48+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1191000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2,2018-04-02,2018-07-01,2019-08-08 16:23:48+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,44000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2,2018-04-02,2018-07-01,2019-08-08 16:23:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6574000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2,2018-04-02,2018-07-01,2019-08-08 16:23:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3976000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2,2018-04-02,2018-07-01,2019-08-08 16:23:48+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,551000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2,2018-04-02,2018-07-01,2019-08-08 16:23:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,551000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2,2018-04-02,2018-07-01,2019-08-08 16:23:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4527000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2,2018-04-02,2018-07-01,2019-08-08 16:23:48+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,648000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2,2018-04-02,2018-07-01,2019-08-08 16:23:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3879000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2,2018-04-02,2018-07-01,2019-08-08 16:23:48+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2,2018-04-02,2018-07-01,2019-08-08 16:23:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3879000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2,2018-04-02,2018-07-01,2019-08-08 16:23:48+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,7000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2,2018-04-02,2018-07-01,2019-08-08 16:23:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3872000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2,2018-04-02,2018-07-01,2019-08-08 16:23:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,5866000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2,2018-04-02,2018-07-01,2019-08-08 16:23:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.66
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2,2018-04-02,2018-07-01,2019-08-08 16:23:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,5952000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2,2018-04-02,2018-07-01,2019-08-08 16:23:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.65
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2,2018-04-02,2018-07-01,2019-08-08 16:23:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,5866700000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2,2018-04-02,2018-07-01,2019-08-08 16:23:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.66
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2,2018-04-02,2018-07-01,2019-08-08 16:23:48+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.34
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2YTD,2018-01-01,2018-07-01,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,26372000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2YTD,2018-01-01,2018-07-01,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,26372000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2YTD,2018-01-01,2018-07-01,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5479000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2YTD,2018-01-01,2018-07-01,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5479000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2YTD,2018-01-01,2018-07-01,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,20893000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2YTD,2018-01-01,2018-07-01,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6954000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2YTD,2018-01-01,2018-07-01,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3540000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2YTD,2018-01-01,2018-07-01,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,2387000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2YTD,2018-01-01,2018-07-01,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,87000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2YTD,2018-01-01,2018-07-01,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12968000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2YTD,2018-01-01,2018-07-01,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7925000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2YTD,2018-01-01,2018-07-01,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,729000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2YTD,2018-01-01,2018-07-01,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,729000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2YTD,2018-01-01,2018-07-01,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8654000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2YTD,2018-01-01,2018-07-01,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1204000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2YTD,2018-01-01,2018-07-01,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7450000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2YTD,2018-01-01,2018-07-01,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-1000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2YTD,2018-01-01,2018-07-01,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7449000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2YTD,2018-01-01,2018-07-01,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,16000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2YTD,2018-01-01,2018-07-01,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7433000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2YTD,2018-01-01,2018-07-01,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,5866000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2YTD,2018-01-01,2018-07-01,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.26
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2YTD,2018-01-01,2018-07-01,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,5952000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2YTD,2018-01-01,2018-07-01,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.24
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2YTD,2018-01-01,2018-07-01,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,5866700000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2YTD,2018-01-01,2018-07-01,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.26
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2YTD,2018-01-01,2018-07-01,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.68
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2TTM,2017-07-03,2018-07-01,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,53241000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2TTM,2017-07-03,2018-07-01,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,53241000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2TTM,2017-07-03,2018-07-01,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,11579000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2TTM,2017-07-03,2018-07-01,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,11579000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2TTM,2017-07-03,2018-07-01,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,41662000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2TTM,2017-07-03,2018-07-01,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15013000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2TTM,2017-07-03,2018-07-01,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7720000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2TTM,2017-07-03,2018-07-01,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4751000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2TTM,2017-07-03,2018-07-01,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,284000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2TTM,2017-07-03,2018-07-01,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27768000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2TTM,2017-07-03,2018-07-01,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,13894000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2TTM,2017-07-03,2018-07-01,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-702000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2TTM,2017-07-03,2018-07-01,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-702000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2TTM,2017-07-03,2018-07-01,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,13193000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2TTM,2017-07-03,2018-07-01,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-9405000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2TTM,2017-07-03,2018-07-01,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,22596000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2TTM,2017-07-03,2018-07-01,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-1000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2TTM,2017-07-03,2018-07-01,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,22596000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2TTM,2017-07-03,2018-07-01,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,49000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2TTM,2017-07-03,2018-07-01,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,22547000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2TTM,2017-07-03,2018-07-01,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,5866000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2TTM,2017-07-03,2018-07-01,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.79
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2TTM,2017-07-03,2018-07-01,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,5952000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2TTM,2017-07-03,2018-07-01,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.74
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2TTM,2017-07-03,2018-07-01,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,5866700000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2TTM,2017-07-03,2018-07-01,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.79
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q2TTM,2017-07-03,2018-07-01,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.04
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1,2018-01-01,2018-04-01,2018-05-10 13:32:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12906000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1,2018-01-01,2018-04-01,2018-05-10 13:32:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12906000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1,2018-01-01,2018-04-01,2018-05-10 13:32:01+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2563000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1,2018-01-01,2018-04-01,2018-05-10 13:32:01+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2563000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1,2018-01-01,2018-04-01,2018-05-10 13:32:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10343000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1,2018-01-01,2018-04-01,2018-05-10 13:32:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3412000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1,2018-01-01,2018-04-01,2018-05-10 13:32:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1743000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1,2018-01-01,2018-04-01,2018-05-10 13:32:01+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1196000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1,2018-01-01,2018-04-01,2018-05-10 13:32:01+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,43000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1,2018-01-01,2018-04-01,2018-05-10 13:32:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6394000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1,2018-01-01,2018-04-01,2018-05-10 13:32:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3949000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1,2018-01-01,2018-04-01,2018-05-10 13:32:01+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,178000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1,2018-01-01,2018-04-01,2018-05-10 13:32:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,178000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1,2018-01-01,2018-04-01,2018-05-10 13:32:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4127000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1,2018-01-01,2018-04-01,2018-05-10 13:32:01+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,556000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1,2018-01-01,2018-04-01,2018-05-10 13:32:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3571000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1,2018-01-01,2018-04-01,2018-05-10 13:32:01+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-1000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1,2018-01-01,2018-04-01,2018-05-10 13:32:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3570000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1,2018-01-01,2018-04-01,2018-05-10 13:32:01+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,9000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1,2018-01-01,2018-04-01,2018-05-10 13:32:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3561000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1,2018-01-01,2018-04-01,2018-05-10 13:32:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,5957000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1,2018-01-01,2018-04-01,2018-05-10 13:32:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.6
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1,2018-01-01,2018-04-01,2018-05-10 13:32:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6057000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1,2018-01-01,2018-04-01,2018-05-10 13:32:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.59
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1,2018-01-01,2018-04-01,2018-05-10 13:32:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,5935000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1,2018-01-01,2018-04-01,2018-05-10 13:32:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.6
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1,2018-01-01,2018-04-01,2018-05-10 13:32:01+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.34
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1TTM,2017-04-03,2018-04-01,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,52671000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1TTM,2017-04-03,2018-04-01,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,52671000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1TTM,2017-04-03,2018-04-01,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,11323000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1TTM,2017-04-03,2018-04-01,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,11323000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1TTM,2017-04-03,2018-04-01,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,41348000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1TTM,2017-04-03,2018-04-01,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14901000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1TTM,2017-04-03,2018-04-01,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7710000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1TTM,2017-04-03,2018-04-01,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4768000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1TTM,2017-04-03,2018-04-01,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,310000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1TTM,2017-04-03,2018-04-01,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27689000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1TTM,2017-04-03,2018-04-01,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,13659000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1TTM,2017-04-03,2018-04-01,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1178000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1TTM,2017-04-03,2018-04-01,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1178000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1TTM,2017-04-03,2018-04-01,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,12481000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1TTM,2017-04-03,2018-04-01,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-9314000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1TTM,2017-04-03,2018-04-01,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,21794000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1TTM,2017-04-03,2018-04-01,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,1000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1TTM,2017-04-03,2018-04-01,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,21795000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1TTM,2017-04-03,2018-04-01,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,47000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1TTM,2017-04-03,2018-04-01,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,21748000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1TTM,2017-04-03,2018-04-01,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,5957000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1TTM,2017-04-03,2018-04-01,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.65
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1TTM,2017-04-03,2018-04-01,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6057000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1TTM,2017-04-03,2018-04-01,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.6
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1TTM,2017-04-03,2018-04-01,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,5935000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1TTM,2017-04-03,2018-04-01,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.65
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2018.0,Q1TTM,2017-04-03,2018-04-01,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.02
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 14:15:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,51750000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 14:15:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,51750000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 14:15:12+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,10219000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 14:15:12+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,10219000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 14:15:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,41531000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 14:15:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14350000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 14:15:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8650000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 14:15:12+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4610000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 14:15:12+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,747000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 14:15:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,28357000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 14:15:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,13174000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 14:15:12+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8086000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 14:15:12+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3578000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 14:15:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,4508000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 14:15:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,17682000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 14:15:12+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1384000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 14:15:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,16298000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 14:15:12+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,4000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 14:15:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,16302000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 14:15:12+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,29000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 14:15:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,16273000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 14:15:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,5569000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 14:15:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.92
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 14:15:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,5675000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 14:15:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.87
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 14:15:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,5572900000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 14:15:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.92
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 14:15:12+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.46
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q4,2019-09-30,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12688000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q4,2019-09-30,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12688000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q4,2019-09-30,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2608000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q4,2019-09-30,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2608000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q4,2019-09-30,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10080000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q4,2019-09-30,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4240000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q4,2019-09-30,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2822000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q4,2019-09-30,2019-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1031000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q4,2019-09-30,2019-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,451000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q4,2019-09-30,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8544000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q4,2019-09-30,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1536000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q4,2019-09-30,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q4,2019-09-30,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3041000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q4,2019-09-30,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3042000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q4,2019-09-30,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1509000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q4,2019-09-30,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1181000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q4,2019-09-30,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-327000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q4,2019-09-30,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-327000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q4,2019-09-30,2019-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,9000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q4,2019-09-30,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-337000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q4,2019-09-30,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,5569000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q4,2019-09-30,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q4,2019-09-30,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,5675000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q4,2019-09-30,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q4,2019-09-30,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,5572900000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q4,2019-09-30,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q4,2019-09-30,2019-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.36
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3YTD,2019-01-01,2019-09-29,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,39062000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3YTD,2019-01-01,2019-09-29,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,39062000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3YTD,2019-01-01,2019-09-29,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7611000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3YTD,2019-01-01,2019-09-29,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7611000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3YTD,2019-01-01,2019-09-29,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,31451000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3YTD,2019-01-01,2019-09-29,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10110000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3YTD,2019-01-01,2019-09-29,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5828000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3YTD,2019-01-01,2019-09-29,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3579000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3YTD,2019-01-01,2019-09-29,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,296000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3YTD,2019-01-01,2019-09-29,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19813000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3YTD,2019-01-01,2019-09-29,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,11638000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3YTD,2019-01-01,2019-09-29,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8087000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3YTD,2019-01-01,2019-09-29,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-537000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3YTD,2019-01-01,2019-09-29,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,7550000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3YTD,2019-01-01,2019-09-29,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,19191000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3YTD,2019-01-01,2019-09-29,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2565000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3YTD,2019-01-01,2019-09-29,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,16625000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3YTD,2019-01-01,2019-09-29,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,4000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3YTD,2019-01-01,2019-09-29,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,16629000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3YTD,2019-01-01,2019-09-29,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,20000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3YTD,2019-01-01,2019-09-29,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,16610000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3YTD,2019-01-01,2019-09-29,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,5545000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3YTD,2019-01-01,2019-09-29,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.98
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3YTD,2019-01-01,2019-09-29,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,5649000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3YTD,2019-01-01,2019-09-29,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.93
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3YTD,2019-01-01,2019-09-29,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,5565200000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3YTD,2019-01-01,2019-09-29,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.98
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3YTD,2019-01-01,2019-09-29,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.36
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3TTM,2018-10-01,2019-09-29,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,53039000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3TTM,2018-10-01,2019-09-29,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,53039000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3TTM,2018-10-01,2019-09-29,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,10686000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3TTM,2018-10-01,2019-09-29,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,10686000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3TTM,2018-10-01,2019-09-29,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,42353000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3TTM,2018-10-01,2019-09-29,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14117000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3TTM,2018-10-01,2019-09-29,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8286000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3TTM,2018-10-01,2019-09-29,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4832000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3TTM,2018-10-01,2019-09-29,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1168000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3TTM,2018-10-01,2019-09-29,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,28403000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3TTM,2018-10-01,2019-09-29,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,13950000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3TTM,2018-10-01,2019-09-29,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8087000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3TTM,2018-10-01,2019-09-29,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3796000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3TTM,2018-10-01,2019-09-29,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,4291000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3TTM,2018-10-01,2019-09-29,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,18245000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3TTM,2018-10-01,2019-09-29,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2001000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3TTM,2018-10-01,2019-09-29,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,16243000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3TTM,2018-10-01,2019-09-29,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,4000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3TTM,2018-10-01,2019-09-29,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,16246000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3TTM,2018-10-01,2019-09-29,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,32000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3TTM,2018-10-01,2019-09-29,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,16216000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3TTM,2018-10-01,2019-09-29,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,5545000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3TTM,2018-10-01,2019-09-29,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.92
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3TTM,2018-10-01,2019-09-29,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,5649000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3TTM,2018-10-01,2019-09-29,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.87
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3TTM,2018-10-01,2019-09-29,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,5565200000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3TTM,2018-10-01,2019-09-29,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.92
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3TTM,2018-10-01,2019-09-29,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.32
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3,2019-07-01,2019-09-29,2019-11-07 15:55:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12680000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3,2019-07-01,2019-09-29,2019-11-07 15:55:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12680000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3,2019-07-01,2019-09-29,2019-11-07 15:55:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2602000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3,2019-07-01,2019-09-29,2019-11-07 15:55:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2602000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3,2019-07-01,2019-09-29,2019-11-07 15:55:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10078000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3,2019-07-01,2019-09-29,2019-11-07 15:55:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3260000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3,2019-07-01,2019-09-29,2019-11-07 15:55:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2283000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3,2019-07-01,2019-09-29,2019-11-07 15:55:42+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1212000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3,2019-07-01,2019-09-29,2019-11-07 15:55:42+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,365000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3,2019-07-01,2019-09-29,2019-11-07 15:55:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7120000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3,2019-07-01,2019-09-29,2019-11-07 15:55:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2958000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3,2019-07-01,2019-09-29,2019-11-07 15:55:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8087000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3,2019-07-01,2019-09-29,2019-11-07 15:55:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-319000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3,2019-07-01,2019-09-29,2019-11-07 15:55:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,7768000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3,2019-07-01,2019-09-29,2019-11-07 15:55:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,10727000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3,2019-07-01,2019-09-29,2019-11-07 15:55:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3047000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3,2019-07-01,2019-09-29,2019-11-07 15:55:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7680000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3,2019-07-01,2019-09-29,2019-11-07 15:55:42+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,4000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3,2019-07-01,2019-09-29,2019-11-07 15:55:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7684000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3,2019-07-01,2019-09-29,2019-11-07 15:55:42+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,4000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3,2019-07-01,2019-09-29,2019-11-07 15:55:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7680000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3,2019-07-01,2019-09-29,2019-11-07 15:55:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,5545000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3,2019-07-01,2019-09-29,2019-11-07 15:55:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.38
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3,2019-07-01,2019-09-29,2019-11-07 15:55:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,5649000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3,2019-07-01,2019-09-29,2019-11-07 15:55:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.36
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3,2019-07-01,2019-09-29,2019-11-07 15:55:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,5565200000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q3,2019-07-01,2019-09-29,2019-11-07 15:55:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.38
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,26382000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,26382000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5009000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5009000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,21373000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6850000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3545000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,2367000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-69000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12693000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,8680000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-218000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-218000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8464000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-482000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8945000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8945000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,16000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2YTD,2019-01-01,2019-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8930000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2YTD,2019-01-01,2019-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,5562000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2YTD,2019-01-01,2019-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.6
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2YTD,2019-01-01,2019-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,5672000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2YTD,2019-01-01,2019-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.57
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2YTD,2019-01-01,2019-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,5545100000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2YTD,2019-01-01,2019-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.6
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2YTD,2019-01-01,2019-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.36
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2TTM,2018-07-02,2019-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,53657000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2TTM,2018-07-02,2019-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,53657000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2TTM,2018-07-02,2019-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,10778000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2TTM,2018-07-02,2019-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,10778000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2TTM,2018-07-02,2019-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,42879000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2TTM,2018-07-02,2019-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14351000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2TTM,2018-07-02,2019-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8011000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2TTM,2018-07-02,2019-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4873000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2TTM,2018-07-02,2019-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,888000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2TTM,2018-07-02,2019-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,28123000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2TTM,2018-07-02,2019-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,14756000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2TTM,2018-07-02,2019-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3063000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2TTM,2018-07-02,2019-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3063000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2TTM,2018-07-02,2019-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,11695000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2TTM,2018-07-02,2019-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-980000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2TTM,2018-07-02,2019-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12674000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2TTM,2018-07-02,2019-06-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,11000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2TTM,2018-07-02,2019-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,12684000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2TTM,2018-07-02,2019-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,36000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2TTM,2018-07-02,2019-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,12650000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2TTM,2018-07-02,2019-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,5562000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2TTM,2018-07-02,2019-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.24
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2TTM,2018-07-02,2019-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,5672000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2TTM,2018-07-02,2019-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.2
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2TTM,2018-07-02,2019-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,5545100000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2TTM,2018-07-02,2019-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.24
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2TTM,2018-07-02,2019-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.32
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:23:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13264000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:23:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13264000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:23:48+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2576000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:23:48+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2576000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:23:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10688000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:23:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3511000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:23:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1842000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:23:48+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1184000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:23:48+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-115000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:23:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6422000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:23:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4266000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:23:48+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-126000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:23:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-126000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:23:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4141000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:23:48+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-915000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:23:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5056000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:23:48+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:23:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5056000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:23:48+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,10000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:23:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5046000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:23:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,5562000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:23:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.91
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:23:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,5672000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:23:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.89
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:23:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,5545100000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:23:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.91
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:23:48+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.36
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 10:42:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13118000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 10:42:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13118000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 10:42:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2433000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 10:42:57+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2433000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 10:42:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10685000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 10:42:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3339000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 10:42:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1703000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 10:42:57+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1183000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 10:42:57+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,46000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 10:42:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6271000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 10:42:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4414000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 10:42:57+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,0.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 10:42:57+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-92000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 10:42:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-92000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 10:42:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4323000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 10:42:57+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,433000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 10:42:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3889000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 10:42:57+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 10:42:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3889000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 10:42:57+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,6000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 10:42:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3884000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 10:42:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,5635000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 10:42:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.69
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 10:42:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,5750000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 10:42:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.68
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 10:42:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,5629000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 10:42:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.69
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 10:42:57+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.36
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1TTM,2018-04-02,2019-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,53859000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1TTM,2018-04-02,2019-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,53859000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1TTM,2018-04-02,2019-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,11118000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1TTM,2018-04-02,2019-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,11118000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1TTM,2018-04-02,2019-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,42741000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1TTM,2018-04-02,2019-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14382000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1TTM,2018-04-02,2019-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7966000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1TTM,2018-04-02,2019-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4880000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1TTM,2018-04-02,2019-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1047000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1TTM,2018-04-02,2019-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,28275000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1TTM,2018-04-02,2019-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,14466000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1TTM,2018-04-02,2019-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2386000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1TTM,2018-04-02,2019-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2386000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1TTM,2018-04-02,2019-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,12081000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1TTM,2018-04-02,2019-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,583000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1TTM,2018-04-02,2019-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11497000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1TTM,2018-04-02,2019-03-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,11000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1TTM,2018-04-02,2019-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,11507000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1TTM,2018-04-02,2019-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,33000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1TTM,2018-04-02,2019-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,11476000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1TTM,2018-04-02,2019-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,5635000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1TTM,2018-04-02,2019-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.99
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1TTM,2018-04-02,2019-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,5750000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1TTM,2018-04-02,2019-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.96
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1TTM,2018-04-02,2019-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,5629000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1TTM,2018-04-02,2019-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.99
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2019.0,Q1TTM,2018-04-02,2019-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.34
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1TTM,2019-04-01,2020-03-29,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,50660000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1TTM,2019-04-01,2020-03-29,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,50660000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1TTM,2019-04-01,2020-03-29,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,10164000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1TTM,2019-04-01,2020-03-29,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,10164000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1TTM,2019-04-01,2020-03-29,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,40496000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1TTM,2019-04-01,2020-03-29,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,13884000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1TTM,2019-04-01,2020-03-29,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8671000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1TTM,2019-04-01,2020-03-29,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4312000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1TTM,2019-04-01,2020-03-29,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,770000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1TTM,2019-04-01,2020-03-29,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27637000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1TTM,2019-04-01,2020-03-29,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,12859000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1TTM,2019-04-01,2020-03-29,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8092000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1TTM,2019-04-01,2020-03-29,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3707000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1TTM,2019-04-01,2020-03-29,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,4385000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1TTM,2019-04-01,2020-03-29,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,17244000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1TTM,2019-04-01,2020-03-29,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1426000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1TTM,2019-04-01,2020-03-29,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,15819000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1TTM,2019-04-01,2020-03-29,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,4000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1TTM,2019-04-01,2020-03-29,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,15823000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1TTM,2019-04-01,2020-03-29,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,32000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1TTM,2019-04-01,2020-03-29,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,15790000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1TTM,2019-04-01,2020-03-29,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,5545000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1TTM,2019-04-01,2020-03-29,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.84
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1TTM,2019-04-01,2020-03-29,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,5613000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1TTM,2019-04-01,2020-03-29,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.8
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1TTM,2019-04-01,2020-03-29,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,5575400000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1TTM,2019-04-01,2020-03-29,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.84
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1,2020-01-01,2020-03-29,2020-05-07 10:42:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12028000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1,2020-01-01,2020-03-29,2020-05-07 10:42:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12028000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1,2020-01-01,2020-03-29,2020-05-07 10:42:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2378000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1,2020-01-01,2020-03-29,2020-05-07 10:42:57+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2378000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1,2020-01-01,2020-03-29,2020-05-07 10:42:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9650000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1,2020-01-01,2020-03-29,2020-05-07 10:42:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2873000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1,2020-01-01,2020-03-29,2020-05-07 10:42:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1724000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1,2020-01-01,2020-03-29,2020-05-07 10:42:57+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,885000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1,2020-01-01,2020-03-29,2020-05-07 10:42:57+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,69000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1,2020-01-01,2020-03-29,2020-05-07 10:42:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5551000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1,2020-01-01,2020-03-29,2020-05-07 10:42:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4099000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1,2020-01-01,2020-03-29,2020-05-07 10:42:57+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,6000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1,2020-01-01,2020-03-29,2020-05-07 10:42:57+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-221000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1,2020-01-01,2020-03-29,2020-05-07 10:42:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-215000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1,2020-01-01,2020-03-29,2020-05-07 10:42:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3885000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1,2020-01-01,2020-03-29,2020-05-07 10:42:57+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,475000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1,2020-01-01,2020-03-29,2020-05-07 10:42:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3410000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1,2020-01-01,2020-03-29,2020-05-07 10:42:57+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1,2020-01-01,2020-03-29,2020-05-07 10:42:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3410000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1,2020-01-01,2020-03-29,2020-05-07 10:42:57+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,9000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1,2020-01-01,2020-03-29,2020-05-07 10:42:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3401000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1,2020-01-01,2020-03-29,2020-05-07 10:42:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,5545000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1,2020-01-01,2020-03-29,2020-05-07 10:42:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.61
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1,2020-01-01,2020-03-29,2020-05-07 10:42:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,5613000000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1,2020-01-01,2020-03-29,2020-05-07 10:42:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.61
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1,2020-01-01,2020-03-29,2020-05-07 10:42:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,5575400000.0
Pfizer Inc,PFE,765LHXWGK1KXCLTFYQ30,0000078003,2020.0,Q1,2020-01-01,2020-03-29,2020-05-07 10:42:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.61
